CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | anthranilic acid |
|
Accession: | CHEBI:30754
|
browse the term
|
Definition: | An aminobenzoic acid that is benzoic acid having a single amino substituent located at position 2. It is a metabolite produced in L-tryptophan-kynurenine pathway in the central nervous system. |
Synonyms: | related_synonym: | 2-AMINOBENZOIC ACID; 2-Aminobenzoesaeure; 2-carboxyaniline; Formula=C7H7NO2; InChI=1S/C7H7NO2/c8-6-4-2-1-3-5(6)7(9)10/h1-4H,8H2,(H,9,10); InChIKey=RWZYAGGXGHYGMB-UHFFFAOYSA-N; SMILES=Nc1ccccc1C(O)=O; Vitamin L1; o-Aminobenzoesaeure; o-aminobenzoic acid; o-carboxyaniline |
| alt_id: | CHEBI:22577; CHEBI:22578; CHEBI:2757; CHEBI:40980 |
| xref: | Beilstein:471803; CAS:118-92-3; DrugBank:DB04166; Gmelin:3397; HMDB:HMDB0001123; KEGG:C00108; KNApSAcK:C00007382 |
| xref_mesh: | MESH:C031385 |
| xref: | MetaCyc:ANTHRANILATE; PDBeChem:BE2; PMID:11680877; PMID:19745702; PMID:20511543; PMID:22321994; PMID:22341575; PMID:22784643; PMID:28166217; PMID:9784247; Reaxys:471803; Wikipedia:Anthranilic_acid |
| cyclic_relationship: | is_conjugate_acid_of CHEBI:16567 |
|
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression |
ISO |
anthranilic acid results in increased expression of AKR1B10 mRNA |
CTD |
PMID:26198647 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
decreases activity |
ISO |
anthranilic acid analog results in decreased activity of AKR1C1 protein |
CTD |
PMID:19007763 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
decreases abundance |
ISO |
IDO1 gene mutant form results in decreased abundance of anthranilic acid |
CTD |
PMID:32871117 |
|
NCBI chr16:67,430,654...67,442,726
Ensembl chr16:67,430,578...67,442,730
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
anthranilic acid analog inhibits the reaction [[IL12A protein binds to IL12B protein] which results in increased secretion of IFNG protein]; anthranilic acid analog inhibits the reaction [IL18 protein results in increased secretion of IFNG protein] |
CTD |
PMID:15799959 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il12a |
interleukin 12A |
multiple interactions |
ISO |
anthranilic acid analog inhibits the reaction [[IL12A protein binds to IL12B protein] which results in increased secretion of IFNG protein] |
CTD |
PMID:15799959 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
anthranilic acid analog inhibits the reaction [[IL12A protein binds to IL12B protein] which results in increased secretion of IFNG protein] |
CTD |
PMID:15799959 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO |
anthranilic acid analog inhibits the reaction [IL18 protein results in increased secretion of IFNG protein] |
CTD |
PMID:15799959 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
EXP |
anthranilic acid analog inhibits the reaction [Streptozocin results in decreased expression of INS1 protein] |
CTD |
PMID:28625491 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
decreases activity |
ISO |
anthranilic acid results in decreased activity of MAP2K1 protein |
CTD |
PMID:18393446 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases activity |
ISO |
anthranilic acid results in increased activity of NFE2L2 protein |
CTD |
PMID:30114225 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
multiple interactions |
ISO |
[oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN1 protein |
CTD |
PMID:22864521 |
|
NCBI chr 3:156,638,811...156,687,503
Ensembl chr 3:156,638,769...156,687,504
|
|
G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
multiple interactions |
ISO |
[oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN11 protein |
CTD |
PMID:22864521 |
|
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
|
|
G |
Ptpn2 |
protein tyrosine phosphatase, non-receptor type 2 |
multiple interactions |
ISO |
[oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN2 protein |
CTD |
PMID:22864521 |
|
NCBI chr18:61,229,012...61,294,662
Ensembl chr18:61,229,014...61,294,627
|
|
G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
multiple interactions |
ISO |
[oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN6 protein |
CTD |
PMID:22864521 |
|
NCBI chr 4:157,526,034...157,550,783
Ensembl chr 4:157,526,035...157,550,984
|
|
G |
Ptpn9 |
protein tyrosine phosphatase, non-receptor type 9 |
multiple interactions |
ISO |
[oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN9 protein |
CTD |
PMID:22864521 |
|
NCBI chr 8:57,391,290...57,472,352
Ensembl chr 8:57,391,259...57,470,952
|
|
G |
Tdo2 |
tryptophan 2,3-dioxygenase |
decreases abundance |
ISO |
TDO2 gene mutant form results in decreased abundance of anthranilic acid |
CTD |
PMID:32871117 |
|
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
|
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
increases response to substance |
ISO |
ADAM17 results in increased susceptibility to fenamic acid |
CTD |
PMID:12147693 |
|
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
decreases activity |
ISO |
fenamic acid analog results in decreased activity of AKR1C1 protein |
CTD |
PMID:19010312 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
decreases activity |
ISO |
fenamic acid analog results in decreased activity of AKR1C2 protein |
CTD |
PMID:19010312 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
decreases activity |
ISO |
fenamic acid analog results in decreased activity of AKR1C3 protein |
CTD |
PMID:19010312 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
multiple interactions |
ISO |
fenamic acid promotes the reaction [VIP protein results in increased expression of AQP3 mRNA] |
CTD |
PMID:12542607 |
|
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
|
|
G |
Cftr |
CF transmembrane conductance regulator |
multiple interactions decreases activity |
ISO EXP |
fenamic acid inhibits the reaction [[[Colforsin co-treated with Genistein] results in increased activity of CFTR protein] which results in increased transport of Iodides]; fenamic acid inhibits the reaction [Colforsin results in increased activity of CFTR protein] fenamic acid results in decreased activity of CFTR protein |
CTD |
PMID:14502435 PMID:14668136 PMID:15020588 PMID:15277574 PMID:15857825 PMID:15921678 PMID:15986093 PMID:16038730 PMID:18230692 More...
|
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
increases expression |
EXP |
fenamic acid results in increased expression of HAVCR1 mRNA |
CTD |
PMID:23142791 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Krt14 |
keratin 14 |
increases expression |
EXP |
fenamic acid results in increased expression of KRT14 mRNA |
CTD |
PMID:23142791 |
|
NCBI chr10:85,137,786...85,142,054
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Lmcd1 |
LIM and cysteine-rich domains 1 |
increases expression |
EXP |
fenamic acid results in increased expression of LMCD1 mRNA |
CTD |
PMID:23558518 |
|
NCBI chr 4:145,393,153...145,452,049
Ensembl chr 4:145,393,145...145,452,046
|
|
G |
Mir210 |
microRNA 210 |
affects expression |
EXP |
fenamic acid affects the expression of MIR210 |
CTD |
PMID:30169741 |
|
NCBI chr 1:196,326,343...196,326,452
Ensembl chr 1:196,326,337...196,326,454
|
|
G |
Mir34c |
microRNA 34c |
increases expression |
EXP |
fenamic acid results in increased expression of MIR34C |
CTD |
PMID:33367795 |
|
NCBI chr 8:51,409,726...51,409,802
Ensembl chr 8:51,409,726...51,409,802
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
increases expression |
EXP |
fenamic acid results in increased expression of TGFB2 mRNA |
CTD |
PMID:23558518 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
fenamic acid inhibits the reaction [TNF protein results in increased transport of Chlorides] |
CTD |
PMID:10783394 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Vip |
vasoactive intestinal peptide |
multiple interactions |
ISO |
fenamic acid promotes the reaction [VIP protein results in increased expression of AQP3 mRNA] |
CTD |
PMID:12542607 |
|
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
|
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
increases response to substance |
ISO |
ADAM17 results in increased susceptibility to Flufenamic Acid |
CTD |
PMID:12147693 |
|
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
decreases activity multiple interactions |
ISO |
Flufenamic Acid results in decreased activity of AKR1C1 protein Flufenamic Acid inhibits the reaction [AKR1C1 protein affects the susceptibility to Oxaliplatin]; Flufenamic Acid inhibits the reaction [AKR1C1 protein results in increased metabolism of Dihydrotestosterone] |
CTD |
PMID:8573067 PMID:12604236 PMID:14672942 PMID:23933386 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
multiple interactions decreases activity |
ISO |
Flufenamic Acid inhibits the reaction [AKR1C2 protein results in increased metabolism of Dihydrotestosterone] Flufenamic Acid results in decreased activity of AKR1C2 protein |
CTD |
PMID:8573067 PMID:12604236 PMID:14672942 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
affects binding multiple interactions decreases activity |
ISO |
Flufenamic Acid binds to AKR1C3 protein Flufenamic Acid inhibits the reaction [AKR1C3 protein affects the susceptibility to oxaliplatin]; Flufenamic Acid inhibits the reaction [AKR1C3 protein results in increased metabolism of Dihydrotestosterone] Flufenamic Acid results in decreased activity of AKR1C3 protein |
CTD |
PMID:12604236 PMID:14672942 PMID:14996743 PMID:23933386 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Ar |
androgen receptor |
multiple interactions decreases expression |
ISO |
Flufenamic Acid analog binds to and results in decreased activity of AR protein; Flufenamic Acid binds to and results in decreased activity of AR protein Flufenamic Acid results in decreased expression of AR mRNA; Flufenamic Acid results in decreased expression of AR protein |
CTD |
PMID:10537180 PMID:19645433 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Asic5 |
acid sensing ion channel subunit family member 5 |
multiple interactions |
ISO |
Flufenamic Acid binds to and results in increased activity of ASIC5 protein |
CTD |
PMID:21828194 |
|
NCBI chr 2:167,307,984...167,336,812
Ensembl chr 2:167,307,984...167,336,812
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions |
ISO |
Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAD protein] |
CTD |
PMID:27957685 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
multiple interactions |
ISO |
Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAK1 protein] |
CTD |
PMID:27957685 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Best1 |
bestrophin 1 |
decreases activity |
ISO |
Flufenamic Acid results in decreased activity of BEST1 protein |
CTD |
PMID:19828819 |
|
NCBI chr 1:206,629,340...206,646,085
Ensembl chr 1:206,629,500...206,646,063
|
|
G |
Bid |
BH3 interacting domain death agonist |
multiple interactions |
ISO |
Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BID protein] |
CTD |
PMID:27957685 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CASP3 protein modified form] |
CTD |
PMID:27957685 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casr |
calcium-sensing receptor |
multiple interactions |
ISO |
Flufenamic Acid promotes the reaction [CASR protein results in increased uptake of Calcium] |
CTD |
PMID:21562303 |
|
NCBI chr11:64,235,251...64,304,811
Ensembl chr11:64,235,251...64,304,811
|
|
G |
Cftr |
CF transmembrane conductance regulator |
decreases activity |
ISO |
Flufenamic Acid results in decreased activity of CFTR protein |
CTD |
PMID:15277574 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Cga |
glycoprotein hormones, alpha polypeptide |
multiple interactions |
EXP |
[Flufenamic Acid results in decreased abundance of Cyclic AMP] which results in decreased expression of CGA mRNA |
CTD |
PMID:8404651 |
|
NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191
|
|
G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
multiple interactions |
ISO |
Flufenamic Acid inhibits the reaction [[Carbachol results in increased activity of CHRM1 protein] which results in increased abundance of Calcium] |
CTD |
PMID:18316702 |
|
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
|
|
G |
Dhrs11 |
dehydrogenase/reductase 11 |
decreases activity |
ISO |
Flufenamic Acid results in decreased activity of DHRS11 protein |
CTD |
PMID:30926317 |
|
NCBI chr10:69,698,214...69,708,294
Ensembl chr10:69,698,214...69,708,295
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions |
EXP |
[Flufenamic Acid results in decreased abundance of Cyclic AMP] which results in decreased expression of FSHB mRNA |
CTD |
PMID:8404651 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Grm1 |
glutamate metabotropic receptor 1 |
multiple interactions |
EXP |
Flufenamic Acid inhibits the reaction [3,5-dihydroxyphenylglycine results in increased activity of GRM1 protein]; Flufenamic Acid inhibits the reaction [[3,5-dihydroxyphenylglycine results in increased activity of GRM1 protein] which results in increased abundance of Calcium] |
CTD |
PMID:14622174 |
|
NCBI chr 1:5,058,285...5,453,170
Ensembl chr 1:5,058,292...5,453,170
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions |
ISO |
Flufenamic Acid inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate] |
CTD |
PMID:23769903 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO |
Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1A protein] |
CTD |
PMID:10866999 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
EXP ISO |
Flufenamic Acid results in increased expression of IL6 mRNA Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] |
CTD |
PMID:15135310 PMID:24849676 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions |
ISO |
E 4031 inhibits the reaction [Flufenamic Acid promotes the reaction [KCNH2 protein results in increased transport of Potassium]]; Flufenamic Acid promotes the reaction [KCNH2 protein results in increased transport of Potassium] |
CTD |
PMID:12359267 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Kcnk10 |
potassium two pore domain channel subfamily K member 10 |
multiple interactions |
ISO |
Flufenamic Acid promotes the reaction [KCNK10 protein results in increased transport of Potassium] |
CTD |
PMID:16075240 |
|
NCBI chr 6:117,690,052...117,826,120
Ensembl chr 6:117,694,222...117,825,695
|
|
G |
Kcnk2 |
potassium two pore domain channel subfamily K member 2 |
multiple interactions |
ISO |
Flufenamic Acid promotes the reaction [KCNK2 protein results in increased transport of Potassium] |
CTD |
PMID:16075240 |
|
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
|
|
G |
Kcnk4 |
potassium two pore domain channel subfamily K member 4 |
multiple interactions |
ISO |
Flufenamic Acid promotes the reaction [KCNK4 protein results in increased transport of Potassium] |
CTD |
PMID:16075240 |
|
NCBI chr 1:204,117,941...204,129,494
Ensembl chr 1:204,114,572...204,125,925
|
|
G |
Kiss1 |
KiSS-1 metastasis-suppressor |
multiple interactions |
ISO |
Flufenamic Acid inhibits the reaction [[KISS1 protein results in increased activity of KISS1R protein] which results in increased abundance of Calcium] |
CTD |
PMID:18948403 |
|
NCBI chr13:44,775,106...44,780,707
Ensembl chr13:44,774,823...44,780,612
|
|
G |
Kiss1r |
KISS1 receptor |
multiple interactions |
ISO |
Flufenamic Acid inhibits the reaction [[KISS1 protein results in increased activity of KISS1R protein] which results in increased abundance of Calcium] |
CTD |
PMID:18948403 |
|
NCBI chr 7:9,785,135...9,790,283
Ensembl chr 7:9,785,135...9,788,793
|
|
G |
Ldlr |
low density lipoprotein receptor |
multiple interactions increases expression |
ISO |
Flufenamic Acid inhibits the reaction [Cyclosporine inhibits the reaction [[Cholesterol, LDL binds to LDLR protein] which results in increased degradation of Cholesterol, LDL]]; Flufenamic Acid promotes the reaction [[Cholesterol, LDL binds to LDLR protein] which results in increased degradation of Cholesterol, LDL]; Flufenamic Acid promotes the reaction [Cholesterol, LDL binds to LDLR protein] Flufenamic Acid results in increased expression of LDLR mRNA; Flufenamic Acid results in increased expression of LDLR protein |
CTD |
PMID:10395027 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lep |
leptin |
multiple interactions |
ISO |
Flufenamic Acid inhibits the reaction [LEP protein results in increased transport of Calcium] |
CTD |
PMID:20107083 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions |
EXP |
[Flufenamic Acid results in decreased abundance of Cyclic AMP] which results in decreased expression of LHB mRNA |
CTD |
PMID:8404651 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Nkx3-1 |
NK3 homeobox 1 |
multiple interactions |
ISO |
Flufenamic Acid inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA] |
CTD |
PMID:10537180 |
|
NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions increases expression |
ISO EXP |
Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] Flufenamic Acid results in increased expression of NOS2 mRNA |
CTD |
PMID:10866999 PMID:15135310 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Panx1 |
Pannexin 1 |
decreases activity |
ISO |
Flufenamic Acid results in decreased activity of PANX1 protein |
CTD |
PMID:19023039 |
|
NCBI chr 8:11,851,176...11,889,774
Ensembl chr 8:11,850,730...11,889,774
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
Flufenamic Acid binds to and results in increased activity of PPARA protein |
CTD |
PMID:9013583 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions increases activity |
ISO |
[Flufenamic Acid results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein; Flufenamic Acid binds to and results in increased activity of PPARG protein |
CTD |
PMID:9013583 PMID:10866999 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
ISO |
[Flufenamic Acid results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein; Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Flufenamic Acid inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] Flufenamic Acid results in increased expression of PTGS2 mRNA; Flufenamic Acid results in increased expression of PTGS2 protein |
CTD |
PMID:10866999 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Sell |
selectin L |
decreases expression |
ISO |
Flufenamic Acid results in decreased expression of SELL protein |
CTD |
PMID:12147693 |
|
NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
|
|
G |
Slc6a11 |
solute carrier family 6 member 11 |
multiple interactions |
ISO |
Flufenamic Acid inhibits the reaction [SLC6A11 protein results in increased uptake of gamma-Aminobutyric Acid] |
CTD |
PMID:15981712 |
|
NCBI chr 4:147,297,972...147,413,319
Ensembl chr 4:147,297,969...147,413,443
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO EXP |
Flufenamic Acid inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] Flufenamic Acid results in increased expression of TNF mRNA |
CTD |
PMID:10866999 PMID:15135310 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
multiple interactions increases activity |
ISO EXP |
[Flufenamic Acid results in increased activity of TRPC6 protein] which results in increased uptake of Calcium Flufenamic Acid inhibits the reaction [1-oleoyl-2-acetoyl-sn-glycerol promotes the reaction [TRPC6 protein results in increased uptake of Calcium]]; Flufenamic Acid inhibits the reaction [1-oleoyl-2-acetoyl-sn-glycerol promotes the reaction [TRPC6 protein results in increased uptake of Manganese]] |
CTD |
PMID:11535132 PMID:14551041 PMID:21562303 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
multiple interactions |
EXP |
Flufenamic Acid inhibits the reaction [Adenosine Diphosphate Ribose promotes the reaction [TRPM2 protein results in increased transport of Calcium]] |
CTD |
PMID:21900507 |
|
NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181
|
|
G |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
decreases activity |
ISO EXP |
Flufenamic Acid results in decreased activity of TRPM4 protein |
CTD |
PMID:16966582 PMID:17188667 |
|
NCBI chr 1:95,781,805...95,812,095
Ensembl chr 1:95,782,000...95,812,532
|
|
|
G |
A2m |
alpha-2-macroglobulin |
increases expression |
EXP |
Glafenine results in increased expression of A2M mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Aadac |
arylacetamide deacetylase |
decreases expression |
EXP |
Glafenine results in decreased expression of AADAC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:144,163,436...144,186,086
Ensembl chr 2:144,135,319...144,174,734
|
|
G |
Aamdc |
adipogenesis associated, Mth938 domain containing |
decreases expression |
EXP |
Glafenine results in decreased expression of AAMDC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:151,861,990...151,893,621
Ensembl chr 1:151,845,255...151,892,398
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
decreases expression |
EXP |
Glafenine results in decreased expression of ABAT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
increases expression |
EXP |
Glafenine results in increased expression of ABCA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
EXP |
Glafenine results in decreased expression of ABCB11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases expression |
EXP |
Glafenine results in decreased expression of ABCB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of ABCC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcd3 |
ATP binding cassette subfamily D member 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of ABCD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:209,852,087...209,905,763
Ensembl chr 2:209,852,087...209,906,020
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
decreases expression |
EXP |
Glafenine results in decreased expression of ABCG5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
|
|
G |
Abhd1 |
abhydrolase domain containing 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ABHD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:25,422,526...25,427,514
Ensembl chr 6:25,422,526...25,427,514
|
|
G |
Abhd14b |
abhydrolase domain containing 14b |
decreases expression |
EXP |
Glafenine results in decreased expression of ABHD14B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:107,087,157...107,092,122
Ensembl chr 8:107,088,069...107,092,119
|
|
G |
Abhd2 |
abhydrolase domain containing 2, acylglycerol lipase |
increases expression |
EXP |
Glafenine results in increased expression of ABHD2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:133,217,403...133,298,564
Ensembl chr 1:133,217,375...133,299,061
|
|
G |
Abhd6 |
abhydrolase domain containing 6, acylglycerol lipase |
decreases expression |
EXP |
Glafenine results in decreased expression of ABHD6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:16,859,740...16,907,094
Ensembl chr15:16,859,738...16,906,985
|
|
G |
Abi1 |
abl-interactor 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ABI1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:85,098,837...85,179,829
Ensembl chr17:85,098,550...85,179,792
|
|
G |
Abraxas2 |
abraxas 2, BRISC complex subunit |
decreases expression |
EXP |
Glafenine results in decreased expression of ABRAXAS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:187,647,078...187,672,660
Ensembl chr 1:187,647,067...187,672,655
|
|
G |
Abtb1 |
ankyrin repeat and BTB domain containing 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ABTB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:121,299,302...121,305,667
Ensembl chr 4:121,299,304...121,305,620
|
|
G |
Abtb2 |
ankyrin repeat and BTB domain containing 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of ABTB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:89,954,726...90,108,549
Ensembl chr 3:89,954,713...90,108,548
|
|
G |
Abtb3 |
ankyrin repeat and BTB domain containing 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of ABTB3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:18,035,151...18,310,718
Ensembl chr 7:18,036,083...18,310,834
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
decreases expression |
EXP |
Glafenine results in decreased expression of ACAA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
increases expression |
EXP |
Glafenine results in increased expression of ACACA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acad10 |
acyl-CoA dehydrogenase family, member 10 |
decreases expression |
EXP |
Glafenine results in decreased expression of ACAD10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:34,901,211...34,943,973
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Acad11 |
acyl-CoA dehydrogenase family, member 11 |
decreases expression |
EXP |
Glafenine results in decreased expression of ACAD11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:104,681,346...104,746,559
Ensembl chr 8:104,681,396...104,746,560
|
|
G |
Acad9 |
acyl-CoA dehydrogenase family, member 9 |
decreases expression |
EXP |
Glafenine results in decreased expression of ACAD9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:118,943,170...118,966,150
Ensembl chr 2:118,943,174...118,966,547
|
|
G |
Acadm |
acyl-CoA dehydrogenase medium chain |
decreases expression |
EXP |
Glafenine results in decreased expression of ACADM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
|
|
G |
Acads |
acyl-CoA dehydrogenase short chain |
decreases expression |
EXP |
Glafenine results in decreased expression of ACADS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:41,493,650...41,502,897
Ensembl chr12:41,493,626...41,502,898
|
|
G |
Acbd5 |
acyl-CoA binding domain containing 5 |
decreases expression |
EXP |
Glafenine results in decreased expression of ACBD5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:85,206,178...85,248,909
Ensembl chr17:85,206,303...85,248,215
|
|
G |
Acer2 |
alkaline ceramidase 2 |
increases expression |
EXP |
Glafenine results in increased expression of ACER2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:101,391,830...101,442,615
Ensembl chr 5:101,391,885...101,442,614
|
|
G |
Ackr3 |
atypical chemokine receptor 3 |
increases expression |
EXP |
Glafenine results in increased expression of ACKR3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
|
|
G |
Acot12 |
acyl-CoA thioesterase 12 |
decreases expression |
EXP |
Glafenine results in decreased expression of ACOT12 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:22,986,867...23,027,538
Ensembl chr 2:22,986,626...23,027,536
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of ACOT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
decreases expression |
EXP |
Glafenine results in decreased expression of ACOT4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ACOX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ACSL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
|
|
G |
Acsm2 |
acyl-CoA synthetase medium-chain family member 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of ACSM2A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:173,916,368...173,955,116
Ensembl chr 1:173,916,368...173,955,116
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of ACSS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
|
|
G |
Actg1 |
actin, gamma 1 |
increases expression |
EXP |
Glafenine results in increased expression of ACTG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
|
|
G |
Adck5 |
aarF domain containing kinase 5 |
decreases expression |
EXP |
Glafenine results in decreased expression of ADCK5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:108,301,623...108,319,439
Ensembl chr 7:108,301,415...108,319,436
|
|
G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
decreases expression |
EXP |
Glafenine results in decreased expression of ADH4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Adhfe1 |
alcohol dehydrogenase, iron containing, 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ADHFE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:9,705,966...9,732,580
Ensembl chr 5:9,705,970...9,732,517
|
|
G |
Adipor2 |
adiponectin receptor 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of ADIPOR2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Adk |
adenosine kinase |
decreases expression |
EXP |
Glafenine results in decreased expression of ADK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:2,863,241...3,246,453
Ensembl chr15:2,863,244...3,246,510
|
|
G |
Adss1 |
adenylosuccinate synthase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ADSS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:131,679,795...131,702,012
Ensembl chr 6:131,679,701...131,701,998
|
|
G |
Adss2 |
adenylosuccinate synthase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of ADSS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:89,769,240...89,799,577
Ensembl chr13:89,769,244...89,799,604
|
|
G |
Adtrp |
androgen-dependent TFPI-regulating protein |
decreases expression |
EXP |
Glafenine results in decreased expression of ADTRP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:22,907,758...22,993,834
Ensembl chr17:22,930,740...22,993,826
|
|
G |
Afm |
afamin |
decreases expression |
EXP |
Glafenine results in decreased expression of AFM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:17,531,022...17,563,868
Ensembl chr14:17,531,024...17,563,870
|
|
G |
Afmid |
arylformamidase |
decreases expression |
EXP |
Glafenine results in decreased expression of AFMID mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:103,046,129...103,061,718
Ensembl chr10:103,046,180...103,061,718
|
|
G |
Agmat |
agmatinase |
decreases expression |
EXP |
Glafenine results in decreased expression of AGMAT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:154,043,665...154,074,278
Ensembl chr 5:154,060,151...154,074,276
|
|
G |
Agmo |
alkylglycerol monooxygenase |
decreases expression |
EXP |
Glafenine results in decreased expression of AGMO mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:53,986,236...54,317,838
Ensembl chr 6:53,986,292...54,317,623
|
|
G |
Ahcy |
adenosylhomocysteinase |
decreases expression |
EXP |
Glafenine results in decreased expression of AHCY mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
|
|
G |
Aimp2 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 |
increases expression |
EXP |
Glafenine results in increased expression of AIMP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:10,701,194...10,710,772
Ensembl chr12:10,701,194...10,710,769
|
|
G |
Ak3 |
adenylate kinase 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of AK3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
increases expression |
EXP |
Glafenine results in increased expression of AKR1A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
decreases expression |
EXP |
Glafenine results in decreased expression of AKR1C1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c12 |
aldo-keto reductase family 1, member C12 |
decreases expression |
EXP |
Glafenine results in decreased expression of AKR1C12 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:66,045,376...66,061,496
Ensembl chr17:66,045,378...66,108,329
|
|
G |
AKR1C3l1 |
aldo-keto reductase family 1 member C3-like 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of AKR1C3L1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:65,847,580...65,881,488
Ensembl chr17:65,835,634...65,881,488
|
|
G |
Akr1e2 |
aldo-keto reductase family 1, member E2 |
decreases expression |
EXP |
Glafenine results in decreased expression of AKR1E2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:65,735,909...65,750,441
Ensembl chr17:65,735,943...65,750,441
|
|
G |
Akr7a2 |
aldo-keto reductase family 7, member A2 |
decreases expression |
EXP |
Glafenine results in decreased expression of AKR7A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
decreases expression |
EXP |
Glafenine results in decreased expression of AKR7A3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Alas1 |
5'-aminolevulinate synthase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ALAS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ALDH1A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ALDH1L1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:123,059,989...123,106,471
Ensembl chr 4:123,060,008...123,106,465
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
decreases expression |
EXP |
Glafenine results in decreased expression of ALDH2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Aldh3a2 |
aldehyde dehydrogenase 3 family, member A2 |
decreases expression |
EXP |
Glafenine results in decreased expression of ALDH3A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
|
|
G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ALDH4A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:151,880,002...151,905,491
Ensembl chr 5:151,830,701...151,925,345
|
|
G |
Aldh5a1 |
aldehyde dehydrogenase 5 family, member A1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ALDH5A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ALDH6A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
|
|
G |
Aldh9a1 |
aldehyde dehydrogenase 9 family, member A1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ALDH9A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:79,505,738...79,522,539
Ensembl chr13:79,505,695...79,540,568
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
increases expression |
EXP |
Glafenine results in increased expression of ALDOA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
|
|
G |
Alg12 |
ALG12, alpha-1,6-mannosyltransferase |
increases expression |
EXP |
Glafenine results in increased expression of ALG12 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:119,895,112...119,909,488
Ensembl chr 7:119,895,120...119,909,458
|
|
G |
Alg2 |
ALG2, alpha-1,3/1,6-mannosyltransferase |
increases expression |
EXP |
Glafenine results in increased expression of ALG2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:61,768,738...61,773,297
Ensembl chr 5:61,768,740...61,773,297
|
|
G |
Alg3 |
ALG3, alpha-1,3- mannosyltransferase |
increases expression |
EXP |
Glafenine results in increased expression of ALG3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:80,300,487...80,306,014
Ensembl chr11:80,300,498...80,307,912
|
|
G |
Amacr |
alpha-methylacyl-CoA racemase |
decreases expression |
EXP |
Glafenine results in decreased expression of AMACR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:59,946,158...59,958,255
Ensembl chr 2:59,946,153...59,958,255
|
|
G |
Amigo3 |
adhesion molecule with Ig like domain 3 |
increases expression |
EXP |
Glafenine results in increased expression of AMIGO3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:108,741,899...108,743,425
Ensembl chr 8:108,693,060...108,744,555
|
|
G |
Amy1 |
amylase alpha 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of AMY1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:201,382,678...201,397,487
Ensembl chr 2:201,382,675...201,397,816
|
|
G |
Ang |
angiogenin |
decreases expression |
EXP |
Glafenine results in decreased expression of ANG mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:24,312,711...24,323,361
|
|
G |
Angptl3 |
angiopoietin-like 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of ANGPTL3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:113,703,012...113,709,957
|
|
G |
Ankrd24 |
ankyrin repeat domain 24 |
increases expression |
EXP |
Glafenine results in increased expression of ANKRD24 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:8,061,634...8,081,142
Ensembl chr 7:8,061,953...8,081,142
|
|
G |
Ankrd46 |
ankyrin repeat domain 46 |
decreases expression |
EXP |
Glafenine results in decreased expression of ANKRD46 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:67,647,202...67,668,180
Ensembl chr 7:67,647,204...67,668,132
|
|
G |
Anks4b |
ankyrin repeat and sterile alpha motif domain containing 4B |
decreases expression |
EXP |
Glafenine results in decreased expression of ANKS4B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:174,534,195...174,557,798
Ensembl chr 1:174,547,473...174,557,797
|
|
G |
Antxr2 |
ANTXR cell adhesion molecule 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of ANTXR2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:11,541,718...11,682,110
Ensembl chr14:11,541,772...11,682,094
|
|
G |
Anxa4 |
annexin A4 |
decreases expression |
EXP |
Glafenine results in decreased expression of ANXA4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
|
|
G |
Apeg3 |
antisense paternally expressed gene 3 |
increases expression |
EXP |
Glafenine results in increased expression of APEG3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:67,121,402...67,122,333
Ensembl chr 1:67,121,900...67,122,181 Ensembl chr 1:67,121,900...67,122,181
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
increases expression |
EXP |
Glafenine results in increased expression of APEX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Apmap |
adipocyte plasma membrane associated protein |
decreases expression |
EXP |
Glafenine results in decreased expression of APMAP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:139,409,021...139,437,296
Ensembl chr 3:139,409,022...139,437,341
|
|
G |
Apoa2 |
apolipoprotein A2 |
decreases expression |
EXP |
Glafenine results in decreased expression of APOA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:83,644,460...83,646,358
Ensembl chr13:83,644,470...83,646,355
|
|
G |
Apol7b |
apolipoprotein L7b |
decreases expression |
EXP |
Glafenine results in decreased expression of APOL7B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:109,118,559...109,149,798
Ensembl chr 7:109,131,064...109,147,649
|
|
G |
Appbp2 |
amyloid beta precursor protein binding protein 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of APPBP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:70,057,774...70,099,877
Ensembl chr10:70,057,774...70,099,835
|
|
G |
Aprt |
adenine phosphoribosyl transferase |
increases expression |
EXP |
Glafenine results in increased expression of APRT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:50,626,201...50,628,491
Ensembl chr19:50,626,202...50,628,431
|
|
G |
Arf4 |
ADP-ribosylation factor 4 |
increases expression |
EXP |
Glafenine results in increased expression of ARF4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:1,896,692...1,913,267
Ensembl chr16:1,896,546...1,913,261
|
|
G |
Arfgap3 |
ADP-ribosylation factor GTPase activating protein 3 |
increases expression |
EXP |
Glafenine results in increased expression of ARFGAP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:114,432,873...114,479,206
Ensembl chr 7:114,432,873...114,479,208
|
|
G |
Arfgef1 |
ADP ribosylation factor guanine nucleotide exchange factor 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ARFGEF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:8,982,061...9,076,326
Ensembl chr 5:8,981,540...9,076,326
|
|
G |
Arfip2 |
ADP-ribosylation factor interacting protein 2 |
increases expression |
EXP |
Glafenine results in increased expression of ARFIP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:159,974,255...159,980,398
Ensembl chr 1:159,974,201...159,980,336
|
|
G |
Arhgap1 |
Rho GTPase activating protein 1 |
increases expression |
EXP |
Glafenine results in increased expression of ARHGAP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:77,621,377...77,643,400
Ensembl chr 3:77,620,655...77,643,396
|
|
G |
Arhgap18 |
Rho GTPase activating protein 18 |
decreases expression |
EXP |
Glafenine results in decreased expression of ARHGAP18 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:18,403,531...18,637,306
Ensembl chr 1:18,403,537...18,637,256
|
|
G |
Arhgap24 |
Rho GTPase activating protein 24 |
decreases expression |
EXP |
Glafenine results in decreased expression of ARHGAP24 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:6,800,624...7,183,877
Ensembl chr14:6,800,631...7,183,823
|
|
G |
Arl6ip1 |
ADP-ribosylation factor like GTPase 6 interacting protein 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ARL6IP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:172,430,475...172,439,990
Ensembl chr 1:172,430,489...172,439,994
|
|
G |
Arl6ip4 |
ADP-ribosylation factor like GTPase 6 interacting protein 4 |
increases expression |
EXP |
Glafenine results in increased expression of ARL6IP4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:32,479,623...32,481,768
Ensembl chr12:32,479,625...32,481,799
|
|
G |
Armc9 |
armadillo repeat containing 9 |
increases expression |
EXP |
Glafenine results in increased expression of ARMC9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:86,802,791...86,928,611
Ensembl chr 9:86,802,868...86,928,860
|
|
G |
Armcx3 |
armadillo repeat containing, X-linked 3 |
increases expression |
EXP |
Glafenine results in increased expression of ARMCX3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:97,937,115...97,942,098
Ensembl chr X:97,936,999...97,942,098
|
|
G |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
increases expression |
EXP |
Glafenine results in increased expression of ARPC1B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:9,482,176...9,495,772
Ensembl chr12:9,480,831...9,495,747
|
|
G |
Arpc5l |
actin related protein 2/3 complex, subunit 5-like |
increases expression |
EXP |
Glafenine results in increased expression of ARPC5L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:22,758,710...22,767,520
Ensembl chr 3:22,759,876...22,767,538 Ensembl chr 9:22,759,876...22,767,538
|
|
G |
Asl |
argininosuccinate lyase |
decreases expression |
EXP |
Glafenine results in decreased expression of ASL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ASS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atf4 |
activating transcription factor 4 |
increases expression |
EXP |
Glafenine results in increased expression of ATF4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atg13 |
autophagy related 13 |
increases expression |
EXP |
Glafenine results in increased expression of ATG13 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:77,647,069...77,681,028
Ensembl chr 3:77,645,790...77,681,043
|
|
G |
Atg16l2 |
autophagy related 16-like 2 |
increases expression |
EXP |
Glafenine results in increased expression of ATG16L2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:155,687,386...155,703,419
Ensembl chr 1:155,684,564...155,703,420
|
|
G |
Atg2b |
autophagy related 2B |
decreases expression |
EXP |
Glafenine results in decreased expression of ATG2B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:124,522,283...124,592,412
Ensembl chr 6:124,525,523...124,592,015
|
|
G |
Atl2 |
atlastin GTPase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of ATL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:15,139,071...15,180,421
Ensembl chr 6:15,139,044...15,180,421
|
|
G |
Atosa |
atos homolog A |
decreases expression |
EXP |
Glafenine results in decreased expression of ATOSA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:75,694,828...75,772,565
Ensembl chr 8:75,695,022...75,772,549
|
|
G |
Atp11a |
ATPase phospholipid transporting 11A |
decreases expression |
EXP |
Glafenine results in decreased expression of ATP11A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:76,657,752...76,767,640
Ensembl chr16:76,657,752...76,767,640
|
|
G |
Atp11c |
ATPase phospholipid transporting 11C |
decreases expression |
EXP |
Glafenine results in decreased expression of ATP11C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:138,564,459...138,752,116
Ensembl chr X:138,565,836...138,751,204
|
|
G |
Atp1b1 |
ATPase Na+/K+ transporting subunit beta 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ATP1B1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
increases expression |
EXP |
Glafenine results in increased expression of ATP2A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Atp5mc1 |
ATP synthase membrane subunit c locus 1 |
increases expression |
EXP |
Glafenine results in increased expression of ATP5MC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:81,024,056...81,026,780
Ensembl chr10:81,023,925...81,027,124 Ensembl chr10:81,023,925...81,027,124
|
|
G |
Atrn |
attractin |
decreases expression |
EXP |
Glafenine results in decreased expression of ATRN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:118,110,320...118,244,326
Ensembl chr 3:118,110,229...118,244,322
|
|
G |
Atxn2 |
ataxin 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of ATXN2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:34,754,132...34,851,175
Ensembl chr12:34,754,137...34,851,479
|
|
G |
Aurkaip1 |
aurora kinase A interacting protein 1 |
increases expression |
EXP |
Glafenine results in increased expression of AURKAIP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:166,435,177...166,436,888
Ensembl chr 5:166,417,508...166,436,882
|
|
G |
B2m |
beta-2 microglobulin |
decreases expression |
EXP |
Glafenine results in decreased expression of B2M mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
|
|
G |
B4galt1 |
beta-1,4-galactosyltransferase 1 |
increases expression |
EXP |
Glafenine results in increased expression of B4GALT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461
|
|
G |
B4gat1 |
beta-1,4-glucuronyltransferase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of B4GAT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:202,343,268...202,345,490
Ensembl chr 1:202,343,240...202,346,065
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
decreases expression |
EXP |
Glafenine results in decreased expression of BAAT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
|
|
G |
Babam1 |
BRISC and BRCA1 A complex member 1 |
increases expression |
EXP |
Glafenine results in increased expression of BABAM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:18,068,830...18,074,938
Ensembl chr16:18,068,884...18,074,923
|
|
G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
increases expression |
EXP |
Glafenine results in increased expression of BASP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043
|
|
G |
Bbln |
bublin coiled coil protein |
increases expression |
EXP |
Glafenine results in increased expression of BBLN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:15,674,577...15,677,322
Ensembl chr 3:15,674,580...15,677,374
|
|
G |
Bbox1 |
gamma-butyrobetaine hydroxylase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of BBOX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458
|
|
G |
Bbs2 |
Bardet-Biedl syndrome 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of BBS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:10,909,653...10,944,998
Ensembl chr19:10,909,619...10,944,993
|
|
G |
Bcl3 |
BCL3, transcription coactivator |
increases expression |
EXP |
Glafenine results in increased expression of BCL3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607
|
|
G |
Bet1l |
Bet1 golgi vesicular membrane trafficking protein-like |
increases expression |
EXP |
Glafenine results in increased expression of BET1L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:195,931,407...195,935,072
Ensembl chr 1:195,931,411...195,935,040
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
increases expression |
EXP |
Glafenine results in increased expression of BHLHE40 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
decreases expression |
EXP |
Glafenine results in decreased expression of BHMT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
|
|
G |
Bhmt2 |
betaine-homocysteine S-methyltransferase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of BHMT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:24,895,525...24,912,475
Ensembl chr 2:24,895,533...24,912,475
|
|
G |
Bloc1s5 |
biogenesis of lysosomal organelles complex 1 subunit 5 |
decreases expression |
EXP |
Glafenine results in decreased expression of BLOC1S5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:26,171,965...26,197,276
Ensembl chr17:26,172,018...26,197,251
|
|
G |
Blvrb |
biliverdin reductase B |
decreases expression |
EXP |
Glafenine results in decreased expression of BLVRB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Bnip1 |
BCL2 interacting protein 1 |
increases expression |
EXP |
Glafenine results in increased expression of BNIP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:16,386,876...16,399,124
Ensembl chr10:16,386,841...16,399,157
|
|
G |
Bnip3l |
BCL2 interacting protein 3 like |
decreases expression |
EXP |
Glafenine results in decreased expression of BNIP3L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
|
|
G |
Bola2-ps4 |
bolA family member 2, pseudogene 4 |
increases expression |
EXP |
Glafenine results in increased expression of BOLA2-PS4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:153,272,435...153,272,781
|
|
G |
Bola3 |
bolA family member 3 |
increases expression |
EXP |
Glafenine results in increased expression of BOLA3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:115,853,350...115,862,797
Ensembl chr 4:115,853,350...115,862,797
|
|
G |
Bop1 |
BOP1 ribosomal biogenesis factor |
increases expression |
EXP |
Glafenine results in increased expression of BOP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:108,172,062...108,195,875
Ensembl chr 7:108,172,066...108,195,931
|
|
G |
Borcs7 |
BLOC-1 related complex subunit 7 |
increases expression |
EXP |
Glafenine results in increased expression of BORCS7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:245,564,347...245,578,182
Ensembl chr 1:245,564,369...245,579,343
|
|
G |
Bphl |
biphenyl hydrolase like |
decreases expression |
EXP |
Glafenine results in decreased expression of BPHL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:30,800,939...30,837,277
Ensembl chr17:30,799,629...30,837,288
|
|
G |
Brd3 |
bromodomain containing 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of BRD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:10,773,163...10,829,675
Ensembl chr 3:10,775,272...10,829,577
|
|
G |
Brix1 |
biogenesis of ribosomes BRX1 |
increases expression |
EXP |
Glafenine results in increased expression of BRIX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:59,450,608...59,461,486
Ensembl chr 2:59,450,614...59,461,495
|
|
G |
Btbd1 |
BTB domain containing 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of BTBD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:135,734,549...135,773,067
Ensembl chr 1:135,734,589...135,771,981
|
|
G |
Btbd6 |
BTB domain containing 6 |
decreases expression |
EXP |
Glafenine results in decreased expression of BTBD6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:132,058,094...132,060,603
Ensembl chr 6:132,058,096...132,060,587
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
EXP |
Glafenine results in increased expression of BTG2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
Btg3 |
BTG anti-proliferation factor 3 |
increases expression |
EXP |
Glafenine results in increased expression of BTG3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:17,030,156...17,046,069
Ensembl chr11:17,030,160...17,046,170
|
|
G |
Bysl |
bystin-like |
increases expression |
EXP |
Glafenine results in increased expression of BYSL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:13,382,806...13,392,557
Ensembl chr 9:13,382,557...13,394,339
|
|
G |
C10h17orf58 |
similar to human chromosome 17 open reading frame 58 |
increases expression |
EXP |
Glafenine results in increased expression of C10H17ORF58 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:91,972,938...91,977,606
Ensembl chr10:91,972,410...91,977,602
|
|
G |
C15h14orf119 |
similar to human chromosome 14 open reading frame 119 |
increases expression |
EXP |
Glafenine results in increased expression of C15H14ORF119 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:28,146,368...28,151,422
Ensembl chr15:28,146,333...28,155,180
|
|
G |
C18h18orf32 |
similar to human chromosome 18 open reading frame 32 |
increases expression |
EXP |
Glafenine results in increased expression of C18H18ORF32 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:68,586,278...68,594,851
Ensembl chr18:68,586,211...68,596,787
|
|
G |
C1qbp |
complement C1q binding protein |
increases expression |
EXP |
Glafenine results in increased expression of C1QBP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:55,699,954...55,704,605
Ensembl chr10:55,699,954...55,704,649
|
|
G |
C4bpb |
complement component 4 binding protein, beta |
increases expression |
EXP |
Glafenine results in increased expression of C4BPB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:42,120,798...42,131,515
Ensembl chr13:42,120,798...42,131,817
|
|
G |
C5 |
complement C5 |
increases expression |
EXP |
Glafenine results in increased expression of C5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
|
|
G |
C5h1orf122 |
similar to human chromosome 1 open reading frame 122 |
increases expression |
EXP |
Glafenine results in increased expression of C5H1ORF122 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:137,109,093...137,110,130
Ensembl chr 5:137,108,633...137,110,929
|
|
G |
C8h11orf54 |
similar to human chromosome 11 open reading frame 54 |
decreases expression |
EXP |
Glafenine results in decreased expression of C8H11ORF54 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:12,123,839...12,146,412
Ensembl chr 8:12,123,823...12,146,473
|
|
G |
C9 |
complement C9 |
increases expression |
EXP |
Glafenine results in increased expression of C9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:55,573,094...55,621,345
Ensembl chr 2:55,572,992...55,621,338
|
|
G |
Cad |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
increases expression |
EXP |
Glafenine results in increased expression of CAD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:25,292,133...25,315,078
Ensembl chr 6:25,292,133...25,319,861
|
|
G |
Calm1 |
calmodulin 1 |
increases expression |
EXP |
Glafenine results in increased expression of CALM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
|
|
G |
Calr |
calreticulin |
increases expression |
EXP |
Glafenine results in increased expression of CALR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Calu |
calumenin |
increases expression |
EXP |
Glafenine results in increased expression of CALU mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
|
|
G |
Caprin1 |
cell cycle associated protein 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CAPRIN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:90,152,305...90,230,447
Ensembl chr 3:90,153,620...90,230,502
|
|
G |
Car14 |
carbonic anhydrase 14 |
decreases expression |
EXP |
Glafenine results in decreased expression of CAR14 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:183,442,263...183,449,231
Ensembl chr 2:183,441,667...183,449,693
|
|
G |
Car3 |
carbonic anhydrase 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of CAR3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Car5a |
carbonic anhydrase 5A |
decreases expression |
EXP |
Glafenine results in decreased expression of CAR5A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:49,973,092...50,002,948
Ensembl chr19:49,973,107...50,002,906
|
|
G |
Car8 |
carbonic anhydrase 8 |
increases expression |
EXP |
Glafenine results in increased expression of CAR8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:21,302,940...21,402,395
Ensembl chr 5:21,305,383...21,402,374
|
|
G |
Cars1 |
cysteinyl-tRNA synthetase 1 |
increases expression |
EXP |
Glafenine results in increased expression of CARS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
|
|
G |
Cars2 |
cysteinyl-tRNA synthetase 2, mitochondrial |
decreases expression |
EXP |
Glafenine results in decreased expression of CARS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:77,945,468...77,987,163
Ensembl chr16:77,950,008...77,987,772
|
|
G |
Cat |
catalase |
decreases expression |
EXP |
Glafenine results in decreased expression of CAT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cav2 |
caveolin 2 |
increases expression |
EXP |
Glafenine results in increased expression of CAV2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:45,616,766...45,624,144
Ensembl chr 4:45,616,712...45,624,244
|
|
G |
Cbr4 |
carbonyl reductase 4 |
decreases expression |
EXP |
Glafenine results in decreased expression of CBR4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:28,629,928...28,684,230
Ensembl chr16:28,617,224...28,645,712
|
|
G |
Ccdc125 |
coiled-coil domain containing 125 |
increases expression |
EXP |
Glafenine results in increased expression of CCDC125 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:31,809,120...31,835,538
Ensembl chr 2:31,809,228...31,850,152
|
|
G |
Ccdc134 |
coiled-coil domain containing 134 |
increases expression |
EXP |
Glafenine results in increased expression of CCDC134 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:113,644,557...113,659,050
Ensembl chr 7:113,644,639...113,659,050
|
|
G |
Ccdc167 |
coiled-coil domain containing 167 |
increases expression |
EXP |
Glafenine results in increased expression of CCDC167 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:7,763,927...7,782,090
Ensembl chr20:7,751,782...7,781,613
|
|
G |
Ccdc28a |
coiled-coil domain containing 28A |
decreases expression |
EXP |
Glafenine results in decreased expression of CCDC28A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:12,857,668...12,872,944
Ensembl chr 1:12,857,666...12,873,003
|
|
G |
Ccdc86 |
coiled-coil domain containing 86 |
increases expression |
EXP |
Glafenine results in increased expression of CCDC86 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:207,590,167...207,596,547
Ensembl chr 1:207,590,168...207,596,544
|
|
G |
Ccng2 |
cyclin G2 |
decreases expression |
EXP |
Glafenine results in decreased expression of CCNG2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Ccni |
cyclin I |
decreases expression |
EXP |
Glafenine results in decreased expression of CCNI mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:14,879,698...14,902,510
Ensembl chr14:14,879,717...14,902,510
|
|
G |
Cd2bp2 |
Cd2 (cytoplasmic tail) binding protein 2 |
increases expression |
EXP |
Glafenine results in increased expression of CD2BP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:181,809,399...181,815,269
Ensembl chr 1:181,809,406...181,813,448
|
|
G |
Cd48 |
Cd48 molecule |
increases expression |
EXP |
Glafenine results in increased expression of CD48 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142
|
|
G |
Cd59b |
CD59b molecule |
decreases expression |
EXP |
Glafenine results in decreased expression of CD59 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
|
|
G |
Cdadc1 |
cytidine and dCMP deaminase domain containing 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CDADC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:33,726,590...33,755,611
Ensembl chr15:33,723,435...33,755,576
|
|
G |
Cdc42se1 |
CDC42 small effector 1 |
increases expression |
EXP |
Glafenine results in increased expression of CDC42SE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:182,805,691...182,813,520
Ensembl chr 2:182,804,925...182,814,028
|
|
G |
Cdc5l |
cell division cycle 5-like |
decreases expression |
EXP |
Glafenine results in decreased expression of CDC5L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:15,564,949...15,603,453
Ensembl chr 9:15,564,767...15,603,450
|
|
G |
Cdh2 |
cadherin 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of CDH2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdip1 |
cell death-inducing p53 target 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CDIP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:10,773,538...10,796,979
Ensembl chr10:10,774,705...10,796,980
|
|
G |
Cdk2ap1 |
cyclin-dependent kinase 2 associated protein 1 |
increases expression |
EXP |
Glafenine results in increased expression of CDK2AP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:32,249,752...32,258,483
Ensembl chr12:32,249,747...32,258,479
|
|
G |
Cdk2ap2 |
cyclin-dependent kinase 2 associated protein 2 |
increases expression |
EXP |
Glafenine results in increased expression of CDK2AP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:201,391,056...201,393,137
Ensembl chr 1:201,391,466...201,393,137
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
increases expression |
EXP |
Glafenine results in increased expression of CDK4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
EXP |
Glafenine results in increased expression of CDKN1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
decreases expression |
EXP |
Glafenine results in decreased expression of CDKN1B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of CDKN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CDO1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
|
|
G |
Ceacam1 |
CEA cell adhesion molecule 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CEACAM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
increases expression |
EXP |
Glafenine results in increased expression of CEBPD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
|
|
G |
Cemip2 |
cell migration inducing hyaluronidase 2 |
increases expression |
EXP |
Glafenine results in increased expression of CEMIP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:219,330,295...219,407,760
Ensembl chr 1:219,337,985...219,407,760
|
|
G |
Cept1 |
choline/ethanolamine phosphotransferase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CEPT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:193,994,220...194,036,141
Ensembl chr 2:193,993,447...194,035,578
|
|
G |
Ces1d |
carboxylesterase 1D |
decreases expression |
EXP |
Glafenine results in decreased expression of CES1D mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Chac2 |
ChaC glutathione specific gamma-glutamylcyclotransferase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of CHAC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:104,720,754...104,728,305
Ensembl chr14:104,720,758...104,728,301
|
|
G |
Chchd6 |
coiled-coil-helix-coiled-coil-helix domain containing 6 |
increases expression |
EXP |
Glafenine results in increased expression of CHCHD6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:121,803,501...122,024,209
Ensembl chr 4:121,792,717...122,024,216
|
|
G |
Chid1 |
chitinase domain containing 1 |
increases expression |
EXP |
Glafenine results in increased expression of CHID1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:196,594,357...196,629,700
Ensembl chr 1:196,587,509...196,629,606
|
|
G |
Chmp4c |
charged multivesicular body protein 4C |
decreases expression |
EXP |
Glafenine results in decreased expression of CHMP4C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:91,391,729...91,428,652
Ensembl chr 2:91,388,530...91,428,668
|
|
G |
Chpf2 |
chondroitin polymerizing factor 2 |
increases expression |
EXP |
Glafenine results in increased expression of CHPF2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:10,578,470...10,585,940
Ensembl chr 4:10,580,462...10,585,916
|
|
G |
Cic |
capicua transcriptional repressor |
increases expression |
EXP |
Glafenine results in increased expression of CIC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:80,853,920...80,880,537
Ensembl chr 1:80,853,920...80,880,532
|
|
G |
Cinp |
cyclin-dependent kinase 2-interacting protein |
increases expression |
EXP |
Glafenine results in increased expression of CINP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:129,878,618...129,899,575
Ensembl chr 6:129,885,570...129,899,480
|
|
G |
Cisd2 |
CDGSH iron sulfur domain 2 |
increases expression |
EXP |
Glafenine results in increased expression of CISD2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:223,828,937...223,853,768
Ensembl chr 2:223,828,937...223,868,946
|
|
G |
Cks1b |
CDC28 protein kinase regulatory subunit 1B |
increases expression |
EXP |
Glafenine results in increased expression of CKS1B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636
|
|
G |
Clcn4 |
chloride voltage-gated channel 4 |
decreases expression |
EXP |
Glafenine results in decreased expression of CLCN4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:23,729,194...23,795,391
Ensembl chr X:23,729,338...23,793,238
|
|
G |
Clic1 |
chloride intracellular channel 1 |
increases expression |
EXP |
Glafenine results in increased expression of CLIC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:3,764,867...3,773,711
Ensembl chr20:3,761,461...3,773,712
|
|
G |
Clpx |
caseinolytic mitochondrial matrix peptidase chaperone subunit X |
decreases expression |
EXP |
Glafenine results in decreased expression of CLPX mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:65,805,460...65,845,643
Ensembl chr 8:65,805,511...65,845,082
|
|
G |
Cmbl |
carboxymethylenebutenolidase homolog |
decreases expression |
EXP |
Glafenine results in decreased expression of CMBL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:82,571,888...82,591,009
|
|
G |
Cmtr1 |
cap methyltransferase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CMTR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:7,722,729...7,782,579
Ensembl chr20:7,709,713...7,766,302
|
|
G |
Cnn2 |
calponin 2 |
increases expression |
EXP |
Glafenine results in increased expression of CNN2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:9,712,505...9,719,678
Ensembl chr 7:9,712,516...9,719,656
|
|
G |
Cnppd1 |
cyclin Pas1/PHO80 domain containing 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CNPPD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:76,633,475...76,640,164
Ensembl chr 9:76,633,477...76,640,188
|
|
G |
Cnpy2 |
canopy FGF signaling regulator 2 |
increases expression |
EXP |
Glafenine results in increased expression of CNPY2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:748,877...754,352
Ensembl chr 7:749,008...755,519
|
|
G |
Cnpy3 |
canopy FGF signaling regulator 3 |
increases expression |
EXP |
Glafenine results in increased expression of CNPY3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:14,233,478...14,247,847
Ensembl chr 9:14,233,428...14,247,831
|
|
G |
Coasy |
Coenzyme A synthase |
decreases expression |
EXP |
Glafenine results in decreased expression of COASY mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:86,014,566...86,018,849
Ensembl chr10:86,014,597...86,018,841
|
|
G |
Cog3 |
component of oligomeric golgi complex 3 |
increases expression |
EXP |
Glafenine results in increased expression of COG3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:51,020,808...51,071,288
Ensembl chr15:51,020,813...51,070,570
|
|
G |
Cog4 |
component of oligomeric golgi complex 4 |
decreases expression |
EXP |
Glafenine results in decreased expression of COG4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:38,820,478...38,854,803
Ensembl chr19:38,820,501...38,854,796
|
|
G |
Col18a1 |
collagen type XVIII alpha 1 chain |
increases expression |
EXP |
Glafenine results in increased expression of COL18A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
increases expression |
EXP |
Glafenine results in increased expression of COL4A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Copa |
COPI coat complex subunit alpha |
increases expression |
EXP |
Glafenine results in increased expression of COPA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:84,546,483...84,586,879
Ensembl chr13:84,545,943...84,586,874
|
|
G |
Cope |
COPI coat complex subunit epsilon |
increases expression |
EXP |
Glafenine results in increased expression of COPE mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:19,114,871...19,125,076
Ensembl chr16:19,114,871...19,128,907
|
|
G |
Copg1 |
COPI coat complex subunit gamma 1 |
increases expression |
EXP |
Glafenine results in increased expression of COPG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:120,366,540...120,392,502
Ensembl chr 4:120,366,542...120,415,616
|
|
G |
Copg2 |
COPI coat complex subunit gamma 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of COPG2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:59,366,086...59,501,591
Ensembl chr 4:59,366,086...59,501,618
|
|
G |
Copz1 |
COPI coat complex subunit zeta 1 |
increases expression |
EXP |
Glafenine results in increased expression of COPZ1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:134,409,523...134,435,661
Ensembl chr 7:134,409,799...134,435,662
|
|
G |
Copz2 |
COPI coat complex subunit zeta 2 |
increases expression |
EXP |
Glafenine results in increased expression of COPZ2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:81,832,441...81,845,514
Ensembl chr10:81,832,418...81,845,514
|
|
G |
Coq10a |
coenzyme Q10A |
decreases expression |
EXP |
Glafenine results in decreased expression of COQ10A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:792,089...798,392
Ensembl chr 7:792,089...800,161
|
|
G |
Coq10b |
coenzyme Q10B |
increases expression |
EXP |
Glafenine results in increased expression of COQ10B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:56,553,751...56,573,671
Ensembl chr 9:56,553,758...56,573,663
|
|
G |
Coq8a |
coenzyme Q8A |
decreases expression |
EXP |
Glafenine results in decreased expression of COQ8A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:91,904,731...91,933,588
Ensembl chr13:91,904,739...91,931,431
|
|
G |
Cotl1 |
coactosin-like F-actin binding protein 1 |
increases expression |
EXP |
Glafenine results in increased expression of COTL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
|
|
G |
Cox5a |
cytochrome c oxidase subunit 5A |
decreases expression |
EXP |
Glafenine results in decreased expression of COX5A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781
|
|
G |
Cox5b |
cytochrome c oxidase subunit 5B |
increases expression |
EXP |
Glafenine results in increased expression of COX5B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:38,921,980...38,923,806
Ensembl chr 9:38,921,967...38,925,052
|
|
G |
Cp |
ceruloplasmin |
increases expression |
EXP |
Glafenine results in increased expression of CP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Cpne3 |
copine 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of CPNE3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:33,014,658...33,063,934
Ensembl chr 5:33,016,307...33,063,934
|
|
G |
Cpne8 |
copine 8 |
increases expression |
EXP |
Glafenine results in increased expression of CPNE8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:121,615,293...121,789,507
Ensembl chr 7:121,615,294...121,790,377
|
|
G |
Cpped1 |
calcineurin-like phosphoesterase domain containing 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CPPED1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:3,701,522...3,821,050
Ensembl chr10:3,701,459...3,821,054
|
|
G |
Cpq |
carboxypeptidase Q |
decreases expression |
EXP |
Glafenine results in decreased expression of PGCP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:64,264,025...64,830,867
Ensembl chr 7:64,264,081...64,724,546
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CPS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of CPT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Crat |
carnitine O-acetyltransferase |
decreases expression |
EXP |
Glafenine results in decreased expression of CRAT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
|
|
G |
Crbn |
cereblon |
decreases expression |
EXP |
Glafenine results in decreased expression of CRBN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:139,701,154...139,719,949
Ensembl chr 4:139,701,094...139,719,938
|
|
G |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of CREB3L3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
|
|
G |
Crebzf |
CREB/ATF bZIP transcription factor |
decreases expression |
EXP |
Glafenine results in decreased expression of CREBZF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:144,416,864...144,423,540
Ensembl chr 1:144,417,446...144,428,553
|
|
G |
Creld2 |
cysteine-rich with EGF-like domains 2 |
increases expression |
EXP |
Glafenine results in increased expression of CRELD2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:119,909,626...119,916,556
Ensembl chr 7:119,909,633...119,916,543
|
|
G |
Crem |
cAMP responsive element modulator |
decreases expression |
EXP |
Glafenine results in decreased expression of CREM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Crls1 |
cardiolipin synthase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CRLS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:120,119,822...120,138,674
Ensembl chr 3:120,119,852...120,138,655
|
|
G |
Crot |
carnitine O-octanoyltransferase |
decreases expression |
EXP |
Glafenine results in decreased expression of CROT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109
|
|
G |
Crybg2 |
crystallin beta-gamma domain containing 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of CRYBG2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:146,286,406...146,318,417
Ensembl chr 5:146,286,925...146,323,666
|
|
G |
Cryl1 |
crystallin, lambda 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CRYL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:31,427,011...31,545,997
Ensembl chr15:31,427,054...31,545,997
|
|
G |
Crym |
crystallin, mu |
decreases expression |
EXP |
Glafenine results in decreased expression of CRYM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633
|
|
G |
Cryz |
crystallin zeta |
decreases expression |
EXP |
Glafenine results in decreased expression of CRYZ mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:243,552,037...243,580,369
Ensembl chr 2:243,552,119...243,579,758
|
|
G |
Csf1 |
colony stimulating factor 1 |
increases expression |
EXP |
Glafenine results in increased expression of CSF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Ctbs |
chitobiase |
decreases expression |
EXP |
Glafenine results in decreased expression of CTBS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:235,340,520...235,355,091
Ensembl chr 2:235,340,547...235,355,091
|
|
G |
Cth |
cystathionine gamma-lyase |
decreases expression |
EXP |
Glafenine results in decreased expression of CTH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Ctnna1 |
catenin alpha 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CTNNA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
|
|
G |
Ctps1 |
CTP synthase 1 |
increases expression |
EXP |
Glafenine results in increased expression of CTPS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180
|
|
G |
Ctsa |
cathepsin A |
decreases expression |
EXP |
Glafenine results in decreased expression of CTSA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:153,569,106...153,574,983
Ensembl chr 3:153,568,381...153,576,215
|
|
G |
Ctsf |
cathepsin F |
decreases expression |
EXP |
Glafenine results in decreased expression of CTSF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:202,152,777...202,158,525
Ensembl chr 1:202,152,728...202,158,525
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
increases expression |
EXP |
Glafenine results in increased expression of CXCL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
decreases expression |
EXP |
Glafenine results in decreased expression of CXCL12 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
decreases expression |
EXP |
Glafenine results in decreased expression of CXCL9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
Cyb5r3 |
cytochrome b5 reductase 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYB5R3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases activity |
ISO |
Glafenine results in decreased activity of CYP1A1 protein |
CTD |
PMID:33814510 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity |
ISO |
Glafenine results in decreased activity of CYP1B1 protein |
CTD |
PMID:33814510 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP27A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP2A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Cyp2a2 |
cytochrome P450, family 2, subfamily a, polypeptide 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP2A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:82,263,833...82,289,487
Ensembl chr 1:82,263,833...82,289,487
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP2B1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP2C11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2d1 |
cytochrome P450, family 2, subfamily d, polypeptide 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP2D1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:113,908,950...113,913,420
Ensembl chr 7:113,908,947...113,922,084
|
|
G |
Cyp2d2 |
cytochrome P450, family 2, subfamily d, polypeptide 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP2D2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:113,935,138...113,939,209
Ensembl chr 7:113,935,138...113,939,209
|
|
G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP2D3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:113,917,711...113,922,068
Ensembl chr 7:113,908,947...113,922,084
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP2D4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp2j3 |
cytochrome P450, family 2, subfamily j, polypeptide 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP2J3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:111,219,921...111,244,987
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP2J4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp2t1 |
cytochrome P450, family 2, subfamily t, polypeptide 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP2T1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:82,446,321...82,451,564
Ensembl chr 1:82,446,921...82,451,563
|
|
G |
Cyp39a1 |
cytochrome P450, family 39, subfamily a, polypeptide 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP39A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:17,230,455...17,306,775
Ensembl chr 9:17,230,455...17,306,775
|
|
G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP3A18 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:8,880,509...8,930,382
Ensembl chr12:8,880,528...8,930,381
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP3A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP3A23-3A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP4A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
G |
Cyp4f1 |
cytochrome P450, family 4, subfamily f, polypeptide 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP4F1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:12,010,850...12,022,497
Ensembl chr 7:12,010,852...12,022,046
|
|
G |
Cyp4f4 |
cytochrome P450, family 4, subfamily f, polypeptide 4 |
decreases expression |
EXP |
Glafenine results in decreased expression of CYP4F4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:11,717,208...11,733,507
Ensembl chr 7:11,717,208...11,733,506
|
|
G |
Dad1 |
defender against cell death 1 |
increases expression |
EXP |
Glafenine results in increased expression of DAD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:27,677,286...27,697,120
Ensembl chr15:27,677,268...27,697,347
|
|
G |
Dao |
D-amino-acid oxidase |
decreases expression |
EXP |
Glafenine results in decreased expression of DAO mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:42,592,342...42,613,046
Ensembl chr12:42,592,343...42,612,741
|
|
G |
Dap |
death-associated protein |
increases expression |
EXP |
Glafenine results in increased expression of DAP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:82,199,206...82,251,771
Ensembl chr 2:82,199,280...82,251,752
|
|
G |
Dcaf11 |
DDB1 and CUL4 associated factor 11 |
decreases expression |
EXP |
Glafenine results in decreased expression of DCAF11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:29,046,744...29,057,450
Ensembl chr15:29,046,826...29,057,669
|
|
G |
Dcaf6 |
DDB1 and CUL4 associated factor 6 |
decreases expression |
EXP |
Glafenine results in decreased expression of DCAF6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:77,626,257...77,727,645
Ensembl chr13:77,626,307...77,727,512
|
|
G |
Dcun1d4 |
defective in cullin neddylation 1 domain containing 4 |
decreases expression |
EXP |
Glafenine results in decreased expression of DCUN1D4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:34,652,723...34,733,122
Ensembl chr14:34,652,723...34,733,207
|
|
G |
Dda1 |
DET1 and DDB1 associated 1 |
increases expression |
EXP |
Glafenine results in increased expression of DDA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:18,156,310...18,163,938
Ensembl chr16:18,156,386...18,163,937
|
|
G |
Ddc |
dopa decarboxylase |
decreases expression |
EXP |
Glafenine results in decreased expression of DDC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
Glafenine results in increased expression of DDIT3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddost |
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit |
increases expression |
EXP |
Glafenine results in increased expression of DDOST mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:150,522,297...150,529,413
Ensembl chr 5:150,522,242...150,529,413
|
|
G |
Ddx39a |
DExD-box helicase 39A |
increases expression |
EXP |
Glafenine results in increased expression of DDX39A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:24,418,743...24,427,422
Ensembl chr19:24,418,114...24,426,954
|
|
G |
Ddx39b |
DExD-box helicase 39B |
increases expression |
EXP |
Glafenine results in increased expression of DDX39B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:3,547,702...3,585,064
Ensembl chr20:3,572,056...3,584,996
|
|
G |
Ddx49 |
DEAD-box helicase 49 |
increases expression |
EXP |
Glafenine results in increased expression of DDX49 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:19,125,388...19,133,042
Ensembl chr16:19,125,384...19,133,616
|
|
G |
Decr2 |
2,4-dienoyl-CoA reductase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of DECR2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:15,104,907...15,113,281
Ensembl chr10:15,002,926...15,118,479
|
|
G |
Dek |
DEK proto-oncogene |
decreases expression |
EXP |
Glafenine results in decreased expression of DEK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,580,843...17,602,808
|
|
G |
Dennd6a |
DENN domain containing 6A |
decreases expression |
EXP |
Glafenine results in decreased expression of DENND6A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:1,837,019...1,885,420
Ensembl chr16:1,837,059...1,885,420
|
|
G |
Depdc7 |
DEP domain containing 7 |
decreases expression |
EXP |
Glafenine results in decreased expression of DEPDC7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:91,099,111...91,121,152
Ensembl chr 3:91,099,835...91,121,124
|
|
G |
Dera |
deoxyribose-phosphate aldolase |
decreases expression |
EXP |
Glafenine results in decreased expression of DERA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:170,663,689...170,742,469
Ensembl chr 4:170,663,665...170,758,865
|
|
G |
Derl1 |
derlin 1 |
increases expression |
EXP |
Glafenine results in increased expression of DERL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:89,404,413...89,427,095
Ensembl chr 7:89,404,417...89,427,145
|
|
G |
Desi2 |
desumoylating isopeptidase 2 |
increases expression |
EXP |
Glafenine results in increased expression of DESI2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:89,961,767...90,011,255
Ensembl chr13:89,961,934...90,016,416
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
increases expression |
EXP |
Glafenine results in increased expression of DHCR24 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
increases expression |
EXP |
Glafenine results in increased expression of DHODH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of DHRS3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
|
|
G |
Dhrs7b |
dehydrogenase/reductase 7B |
increases expression |
EXP |
Glafenine results in increased expression of DHRS7B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:45,504,344...45,537,094
Ensembl chr10:45,504,426...45,537,076
|
|
G |
Dhtkd1 |
dehydrogenase E1 and transketolase domain containing 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of DHTKD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:72,355,201...72,406,725
Ensembl chr17:72,355,201...72,406,723
|
|
G |
Dmbt1 |
deleted in malignant brain tumors 1 |
increases expression |
EXP |
Glafenine results in increased expression of DMBT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:185,617,469...185,696,476
Ensembl chr 1:185,617,294...185,696,478
|
|
G |
Dmgdh |
dimethylglycine dehydrogenase |
decreases expression |
EXP |
Glafenine results in decreased expression of DMGDH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:24,912,600...24,987,533
Ensembl chr 2:24,912,578...24,987,528
|
|
G |
Dnaaf9 |
dynein axonemal assembly factor 9 |
decreases expression |
EXP |
Glafenine results in decreased expression of DNAAF9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:117,918,047...118,052,641
Ensembl chr 3:117,921,620...118,052,630
|
|
G |
Dnajb11 |
DnaJ heat shock protein family (Hsp40) member B11 |
increases expression |
EXP |
Glafenine results in increased expression of DNAJB11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:78,151,750...78,168,259
Ensembl chr11:78,150,429...78,180,407
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
increases expression |
EXP |
Glafenine results in increased expression of DNAJB9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
|
|
G |
Dnajc15 |
DnaJ heat shock protein family (Hsp40) member C15 |
increases expression |
EXP |
Glafenine results in increased expression of DNAJC15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:53,182,060...53,249,675
Ensembl chr15:53,184,855...53,249,675
|
|
G |
Dnajc3 |
DnaJ heat shock protein family (Hsp40) member C3 |
increases expression |
EXP |
Glafenine results in increased expression of DNAJC3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:96,025,605...96,068,585
Ensembl chr15:96,025,624...96,065,181
|
|
G |
Dnlz |
DNL-type zinc finger |
increases expression |
EXP |
Glafenine results in increased expression of DNLZ mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:9,169,948...9,171,727
Ensembl chr 3:9,169,793...9,180,551
|
|
G |
Dock9 |
dedicator of cytokinesis 9 |
decreases expression |
EXP |
Glafenine results in decreased expression of DOCK9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:98,611,518...98,883,306
Ensembl chr15:98,618,084...98,883,153
|
|
G |
Dpagt1 |
dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 |
increases expression |
EXP |
Glafenine results in increased expression of DPAGT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:44,664,055...44,671,102
Ensembl chr 8:44,664,071...44,671,087
|
|
G |
Dph1 |
diphthamide biosynthesis 1 |
increases expression |
EXP |
Glafenine results in increased expression of DPH1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:60,028,081...60,039,764
Ensembl chr10:60,026,048...60,039,850
|
|
G |
Dph3 |
diphthamide biosynthesis 3 |
increases expression |
EXP |
Glafenine results in increased expression of DPH3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:7,288,295...7,293,734
Ensembl chr16:7,282,705...7,291,265
|
|
G |
Dph5 |
diphthamide biosynthesis 5 |
increases expression |
EXP |
Glafenine results in increased expression of DPH5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:203,804,620...203,858,196
Ensembl chr 2:203,804,936...203,840,433
|
|
G |
Dpm3 |
dolichyl-phosphate mannosyltransferase subunit 3, regulatory |
increases expression |
EXP |
Glafenine results in increased expression of DPM3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:174,676,532...174,677,047
Ensembl chr 2:174,676,363...174,677,668 Ensembl chr15:174,676,363...174,677,668
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
decreases expression |
EXP |
Glafenine results in decreased expression of DPP4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
decreases expression |
EXP |
Glafenine results in decreased expression of DPYD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Dpys |
dihydropyrimidinase |
decreases expression |
EXP |
Glafenine results in decreased expression of DPYS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:70,822,648...70,929,255
Ensembl chr 7:70,835,789...70,929,231
|
|
G |
Dram2 |
DNA damage regulated autophagy modulator 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of DRAM2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:194,035,624...194,064,415
Ensembl chr 2:194,035,818...194,063,403
|
|
G |
Drap1 |
Dr1 associated protein 1 |
increases expression |
EXP |
Glafenine results in increased expression of DRAP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:202,731,775...202,734,468
Ensembl chr 1:202,731,788...202,734,425
|
|
G |
Dsc2 |
desmocollin 2 |
increases expression |
EXP |
Glafenine results in increased expression of DSC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
|
|
G |
Dsp |
desmoplakin |
decreases expression |
EXP |
Glafenine results in decreased expression of DSP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:26,623,602...26,671,692
Ensembl chr17:26,623,588...26,671,800
|
|
G |
Dusp11 |
dual specificity phosphatase 11 |
increases expression |
EXP |
Glafenine results in increased expression of DUSP11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:118,367,673...118,385,183
Ensembl chr 4:118,368,053...118,385,181
|
|
G |
Dynll1 |
dynein light chain LC8-type 1 |
increases expression |
EXP |
Glafenine results in increased expression of DYNLL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:41,312,365...41,316,157
Ensembl chr12:41,312,367...41,314,741
|
|
G |
Dynlt1 |
dynein light chain Tctex-type 1 |
increases expression |
EXP |
Glafenine results in increased expression of DYNLT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:46,887,017...46,893,956
Ensembl chr 1:46,887,017...46,893,881
|
|
G |
Dynlt3 |
dynein light chain Tctex-type 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of DYNLT3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:13,327,933...13,337,139
Ensembl chr X:13,327,892...13,337,139
|
|
G |
Dyrk2 |
dual specificity tyrosine phosphorylation regulated kinase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of DYRK2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:54,348,724...54,381,363
Ensembl chr 7:54,349,610...54,380,106
|
|
G |
Ebna1bp2 |
EBNA1 binding protein 2 |
increases expression |
EXP |
Glafenine results in increased expression of EBNA1BP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:132,148,164...132,152,730
Ensembl chr 5:132,148,143...132,153,267
|
|
G |
Echdc3 |
enoyl CoA hydratase domain containing 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of ECHDC3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:72,070,697...72,093,519
Ensembl chr17:72,070,668...72,093,516
|
|
G |
Eci2 |
enoyl-CoA delta isomerase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of ECI2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:29,850,884...29,886,781
Ensembl chr17:29,870,391...29,886,781
|
|
G |
Edem1 |
ER degradation enhancing alpha-mannosidase like protein 1 |
increases expression |
EXP |
Glafenine results in increased expression of EDEM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
|
|
G |
Edem2 |
ER degradation enhancing alpha-mannosidase like protein 2 |
increases expression |
EXP |
Glafenine results in increased expression of EDEM2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:144,201,604...144,227,423
Ensembl chr 3:144,201,605...144,227,485
|
|
G |
Eef1b2 |
eukaryotic translation elongation factor 1 beta 2 |
increases expression |
EXP |
Glafenine results in increased expression of EEF1B2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:64,580,163...64,582,737
Ensembl chr 9:64,579,893...64,582,737
|
|
G |
Eef1g |
eukaryotic translation elongation factor 1 gamma |
increases expression |
EXP |
Glafenine results in increased expression of EEF1G mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:205,860,713...205,871,319
Ensembl chr 1:205,860,698...205,872,382
|
|
G |
Eepd1 |
endonuclease/exonuclease/phosphatase family domain containing 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of EEPD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:23,957,258...24,064,343
Ensembl chr 8:23,957,255...24,064,340
|
|
G |
Efr3a |
EFR3 homolog A |
decreases expression |
EXP |
Glafenine results in decreased expression of EFR3A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:97,552,677...97,633,369
Ensembl chr 7:97,552,677...97,633,369
|
|
G |
Egf |
epidermal growth factor |
decreases expression |
EXP |
Glafenine results in decreased expression of EGF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfl7 |
EGF-like-domain, multiple 7 |
increases expression |
EXP |
Glafenine results in increased expression of EGFL7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:9,404,622...9,416,879
Ensembl chr 3:9,407,520...9,416,879
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression |
EXP |
Glafenine results in decreased expression of EGFR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Ehhadh |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
decreases expression |
EXP |
Glafenine results in decreased expression of EHHADH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
|
|
G |
Ei24 |
EI24, autophagy associated transmembrane protein |
decreases expression |
EXP |
Glafenine results in decreased expression of EI24 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:36,494,289...36,510,653
Ensembl chr 8:36,494,289...36,510,571
|
|
G |
Eif1ad |
eukaryotic translation initiation factor 1A domain containing |
increases expression |
EXP |
Glafenine results in increased expression of EIF1AD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:202,674,362...202,679,662
Ensembl chr 1:202,674,185...202,679,658
|
|
G |
Eif2ak1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of EIF2AK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:10,710,771...10,744,597
Ensembl chr12:10,705,874...10,744,573
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
increases expression |
EXP |
Glafenine results in increased expression of EIF2S1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eif2s3 |
eukaryotic translation initiation factor 2 subunit gamma |
decreases expression |
EXP |
Glafenine results in decreased expression of EIF2S3X mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:58,916,513...58,939,923
Ensembl chr X:58,917,490...58,940,686
|
|
G |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
increases expression |
EXP |
Glafenine results in increased expression of EIF3B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:14,196,403...14,220,865
Ensembl chr12:14,196,403...14,220,886
|
|
G |
Eif3i |
eukaryotic translation initiation factor 3, subunit I |
increases expression |
EXP |
Glafenine results in increased expression of EIF3I mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:141,935,135...141,942,589
Ensembl chr 5:141,935,044...141,942,676
|
|
G |
Eif4a1 |
eukaryotic translation initiation factor 4A1 |
increases expression |
EXP |
Glafenine results in increased expression of EIF4A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:54,384,345...54,389,855
Ensembl chr10:54,384,347...54,389,858
|
|
G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
decreases expression |
EXP |
Glafenine results in decreased expression of EIF4A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:77,764,126...77,770,810
Ensembl chr11:77,764,124...77,770,781
|
|
G |
Eif4b |
eukaryotic translation initiation factor 4B |
decreases expression |
EXP |
Glafenine results in decreased expression of EIF4B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:133,206,637...133,228,436
|
|
G |
Eif4g1 |
eukaryotic translation initiation factor 4 gamma 1 |
increases expression |
EXP |
Glafenine results in increased expression of EIF4G1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:80,221,919...80,241,958
Ensembl chr11:80,221,919...80,241,941
|
|
G |
Eif5a |
eukaryotic translation initiation factor 5A |
increases expression |
EXP |
Glafenine results in increased expression of EIF5A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:54,640,104...54,644,845
Ensembl chr10:54,640,024...54,644,656
|
|
G |
Eif6 |
eukaryotic translation initiation factor 6 |
increases expression |
EXP |
Glafenine results in increased expression of EIF6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401
|
|
G |
Eipr1 |
EARP complex and GARP complex interacting protein 1 |
increases expression |
EXP |
Glafenine results in increased expression of EIPR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:45,388,451...45,502,089
Ensembl chr 6:45,388,376...45,502,083
|
|
G |
Ell3 |
elongation factor for RNA polymerase II 3 |
increases expression |
EXP |
Glafenine results in increased expression of ELL3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:108,413,035...108,417,181
Ensembl chr 3:108,410,448...108,417,132
|
|
G |
Elob |
elongin B |
increases expression |
EXP |
Glafenine results in increased expression of ELOB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:12,848,830...12,853,897
Ensembl chr10:12,848,827...12,853,635
|
|
G |
Elof1 |
elongation factor 1 |
increases expression |
EXP |
Glafenine results in increased expression of ELOF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:20,645,336...20,650,888
Ensembl chr 8:20,645,336...20,650,579
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
increases expression |
EXP |
Glafenine results in increased expression of ELOVL6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
|
|
G |
Emc6 |
ER membrane protein complex subunit 6 |
increases expression |
EXP |
Glafenine results in increased expression of EMC6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:57,794,072...57,795,671
Ensembl chr10:57,793,685...57,796,217
|
|
G |
Emilin1 |
elastin microfibril interfacer 1 |
increases expression |
EXP |
Glafenine results in increased expression of EMILIN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:25,455,974...25,463,713
Ensembl chr 6:25,445,298...25,463,698
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
increases expression |
EXP |
Glafenine results in increased expression of ENC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
|
|
G |
Eng |
endoglin |
increases expression |
EXP |
Glafenine results in increased expression of ENG mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
|
|
G |
Enpep |
glutamyl aminopeptidase |
decreases expression |
EXP |
Glafenine results in decreased expression of ENPEP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:217,781,985...217,851,947
Ensembl chr 2:217,782,005...217,851,947
|
|
G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of ENPP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
|
|
G |
Enpp3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of ENPP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:20,563,700...20,635,044
Ensembl chr 1:20,563,697...20,635,041
|
|
G |
Eola2 |
endothelium and lymphocyte associated ASCH domain 2 |
increases expression |
EXP |
Glafenine results in increased expression of EOLA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:149,064,015...149,068,627
Ensembl chr X:149,064,041...149,068,627
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of EPHX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Eprs1 |
glutamyl-prolyl-tRNA synthetase 1 |
increases expression |
EXP |
Glafenine results in increased expression of EPRS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
|
|
G |
Eps8l2 |
EPS8-like 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of EPS8L2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:196,446,260...196,471,544
Ensembl chr 1:196,446,287...196,471,541
|
|
G |
Erg28 |
ergosterol biosynthesis 28 homolog |
increases expression |
EXP |
Glafenine results in increased expression of ERG28 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:105,474,112...105,483,078
Ensembl chr 6:105,474,113...105,483,078
|
|
G |
Erh |
ERH, mRNA splicing and mitosis factor |
increases expression |
EXP |
Glafenine results in increased expression of ERH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:100,280,933...100,291,200
Ensembl chr 6:100,280,930...100,291,210
|
|
G |
Erp29 |
endoplasmic reticulum protein 29 |
increases expression |
EXP |
Glafenine results in increased expression of ERP29 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
|
|
G |
Erp44 |
endoplasmic reticulum protein 44 |
increases expression |
EXP |
Glafenine results in increased expression of ERP44 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:62,516,550...62,610,762
Ensembl chr 5:62,516,551...62,610,761
|
|
G |
Esam |
endothelial cell adhesion molecule |
increases expression |
EXP |
Glafenine results in increased expression of ESAM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:37,238,228...37,249,217
Ensembl chr 8:37,238,287...37,249,215
|
|
G |
Etfdh |
electron transfer flavoprotein dehydrogenase |
decreases expression |
EXP |
Glafenine results in decreased expression of ETFDH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:164,740,547...164,762,754
Ensembl chr 2:164,729,749...164,762,745
|
|
G |
Ethe1 |
ETHE1, persulfide dioxygenase |
decreases expression |
EXP |
Glafenine results in decreased expression of ETHE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:80,184,037...80,199,092
Ensembl chr 1:80,183,894...80,199,052
|
|
G |
Faah |
fatty acid amide hydrolase |
decreases expression |
EXP |
Glafenine results in decreased expression of FAAH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
increases expression |
EXP |
Glafenine results in increased expression of FABP4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fabp5 |
fatty acid binding protein 5 |
increases expression |
EXP |
Glafenine results in increased expression of FABP5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:91,765,056...91,853,773
|
|
G |
Fads1 |
fatty acid desaturase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of FADS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
|
|
G |
Fads2 |
fatty acid desaturase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of FADS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
|
|
G |
Fahd2a |
fumarylacetoacetate hydrolase domain containing 2A |
decreases expression |
EXP |
Glafenine results in decreased expression of FAHD2A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:114,657,176...114,665,349
Ensembl chr 3:114,655,865...114,665,356
|
|
G |
Fam114a1 |
family with sequence similarity 114, member A1 |
increases expression |
EXP |
Glafenine results in increased expression of FAM114A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:43,275,693...43,346,154
Ensembl chr14:43,275,701...43,346,174
|
|
G |
Fam117b |
family with sequence similarity 117, member B |
decreases expression |
EXP |
Glafenine results in decreased expression of FAM117B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:61,340,284...61,418,531
Ensembl chr 9:61,340,249...61,408,483
|
|
G |
Fam167b |
family with sequence similarity 167, member B |
increases expression |
EXP |
Glafenine results in increased expression of FAM167B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:141,920,695...141,922,342
Ensembl chr 5:141,920,695...141,922,340
|
|
G |
Fam210a |
family with sequence similarity 210, member A |
decreases expression |
EXP |
Glafenine results in decreased expression of FAM210A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:61,846,447...61,886,123
Ensembl chr18:61,852,907...61,886,171
|
|
G |
Fam210b |
family with sequence similarity 210, member B |
decreases expression |
EXP |
Glafenine results in decreased expression of FAM210B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:161,118,228...161,128,400
Ensembl chr 3:161,118,239...161,128,397
|
|
G |
Fam241b |
family with sequence similarity 241 member B |
decreases expression |
EXP |
Glafenine results in decreased expression of FAM241B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:30,052,315...30,055,247
Ensembl chr20:30,052,324...30,055,084
|
|
G |
Fam3c |
FAM3 metabolism regulating signaling molecule C |
increases expression |
EXP |
Glafenine results in increased expression of FAM3C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:50,839,929...50,887,276
Ensembl chr 4:50,838,818...50,888,078
|
|
G |
Farsb |
phenylalanyl-tRNA synthetase subunit beta |
increases expression |
EXP |
Glafenine results in increased expression of FARSB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:79,887,852...79,947,082
Ensembl chr 9:79,887,842...79,947,045
|
|
G |
Fasn |
fatty acid synthase |
increases expression |
EXP |
Glafenine results in increased expression of FASN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fastk |
Fas-activated serine/threonine kinase |
increases expression |
EXP |
Glafenine results in increased expression of FASTK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:10,732,273...10,736,332
Ensembl chr 4:10,732,256...10,737,430
|
|
G |
Fbl |
fibrillarin |
increases expression |
EXP |
Glafenine results in increased expression of FBL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:83,469,832...83,478,932
Ensembl chr 1:83,469,832...83,478,932
|
|
G |
Fbxo3 |
F-box protein 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of FBXO3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:90,417,262...90,449,557
Ensembl chr 3:90,417,297...90,449,557
|
|
G |
Fbxo7 |
F-box protein 7 |
decreases expression |
EXP |
Glafenine results in decreased expression of FBXO7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:17,809,224...17,837,549
Ensembl chr 7:17,809,231...17,837,530
|
|
G |
Fcgr2b |
Fc gamma receptor 2B |
increases expression |
EXP |
Glafenine results in increased expression of FCGR2B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
|
|
G |
Fchsd2 |
FCH and double SH3 domains 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of FCHSD2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:155,444,471...155,685,350
Ensembl chr 1:155,444,460...155,685,539
|
|
G |
Fdps |
farnesyl diphosphate synthase |
increases expression |
EXP |
Glafenine results in increased expression of FDPS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
|
|
G |
Fdx1 |
ferredoxin 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of FDX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:52,268,536...52,287,344
Ensembl chr 8:52,268,536...52,287,414
|
|
G |
Fdxr |
ferredoxin reductase |
decreases expression |
EXP |
Glafenine results in decreased expression of FDXR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658
|
|
G |
Fech |
ferrochelatase |
decreases expression |
EXP |
Glafenine results in decreased expression of FECH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
|
|
G |
Fermt2 |
FERM domain containing kindlin 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of FERMT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:18,682,927...18,751,959
Ensembl chr15:18,682,927...18,751,811
|
|
G |
Fga |
fibrinogen alpha chain |
increases expression |
EXP |
Glafenine results in increased expression of FGA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
|
|
G |
Fgl1 |
fibrinogen-like 1 |
increases expression |
EXP |
Glafenine results in increased expression of FGL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:51,120,652...51,150,907
Ensembl chr16:51,120,694...51,151,093
|
|
G |
Fis1 |
fission, mitochondrial 1 |
increases expression |
EXP |
Glafenine results in increased expression of FIS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377
|
|
G |
Fitm2 |
fat storage-inducing transmembrane protein 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of FITM2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:152,141,346...152,147,858
Ensembl chr 3:152,141,346...152,147,858
|
|
G |
Fkbp11 |
FKBP prolyl isomerase 11 |
increases expression |
EXP |
Glafenine results in increased expression of FKBP11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
increases expression |
EXP |
Glafenine results in increased expression of FKBP5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
|
|
G |
Flad1 |
flavin adenine dinucleotide synthetase 1 |
increases expression |
EXP |
Glafenine results in increased expression of FLAD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:174,819,451...174,828,921
Ensembl chr 2:174,819,453...174,828,977
|
|
G |
Flcn |
folliculin |
decreases expression |
EXP |
Glafenine results in decreased expression of FLCN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:44,588,621...44,607,808
Ensembl chr10:44,588,624...44,607,769
|
|
G |
Flna |
filamin A |
increases expression |
EXP |
Glafenine results in increased expression of FLNA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:152,007,758...152,034,266
Ensembl chr X:152,007,758...152,031,052
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of FMO1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
|
|
G |
Fmo3 |
flavin containing dimethylaniline monoxygenase 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of FMO3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
|
|
G |
Fn1 |
fibronectin 1 |
increases expression |
EXP |
Glafenine results in increased expression of FN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fn3krp |
fructosamine-3-kinase-related protein |
decreases expression |
EXP |
Glafenine results in decreased expression of FN3KRP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:106,688,413...106,697,137
Ensembl chr10:106,688,439...106,697,134
|
|
G |
Fndc3b |
fibronectin type III domain containing 3B |
increases expression |
EXP |
Glafenine results in increased expression of FNDC3B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:110,311,439...110,617,504
Ensembl chr 2:110,312,694...110,547,830
|
|
G |
Foxa2 |
forkhead box A2 |
decreases expression |
EXP |
Glafenine results in decreased expression of FOXA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
|
|
G |
Foxa3 |
forkhead box A3 |
increases expression |
EXP |
Glafenine results in increased expression of FOXA3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:78,662,067...78,672,321
Ensembl chr 1:78,662,431...78,672,155
|
|
G |
Foxn3 |
forkhead box N3 |
decreases expression |
EXP |
Glafenine results in decreased expression of FOXN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:118,462,018...118,842,442
Ensembl chr 6:118,466,025...118,842,401
|
|
G |
Fpgs |
folylpolyglutamate synthase |
increases expression |
EXP |
Glafenine results in increased expression of FPGS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:15,972,800...15,993,592
Ensembl chr 3:15,972,800...15,993,563
|
|
G |
Ftcd |
formimidoyltransferase cyclodeaminase |
decreases expression |
EXP |
Glafenine results in decreased expression of FTCD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:12,055,203...12,068,717
Ensembl chr20:12,055,208...12,068,735
|
|
G |
Ftsj3 |
FtsJ RNA 2'-O-methyltransferase 3 |
increases expression |
EXP |
Glafenine results in increased expression of FTSJ3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:91,180,945...91,187,389
Ensembl chr10:91,180,696...91,187,397
|
|
G |
Fuca2 |
alpha-L-fucosidase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of FUCA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:7,885,986...7,900,777
Ensembl chr 1:7,885,918...7,900,776
|
|
G |
Fundc2 |
FUN14 domain containing 2 |
increases expression |
EXP |
Glafenine results in increased expression of FUNDC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:128,473...138,232
Ensembl chr18:132,248...138,345
|
|
G |
Fus |
Fus RNA binding protein |
increases expression |
EXP |
Glafenine results in increased expression of FUS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:182,576,479...182,590,417
Ensembl chr 1:182,576,545...182,590,414
|
|
G |
Fut8 |
fucosyltransferase 8 |
increases expression |
EXP |
Glafenine results in increased expression of FUT8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:95,949,246...96,176,677
Ensembl chr 6:95,949,991...96,176,677
|
|
G |
Fxr1 |
FMR1 autosomal homolog 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of FXR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:116,884,167...116,937,590
Ensembl chr 2:116,884,248...116,937,590
|
|
G |
Fyco1 |
FYVE and coiled-coil domain autophagy adaptor 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of FYCO1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:123,412,105...123,479,315
Ensembl chr 8:123,412,112...123,479,021
|
|
G |
Fzd8 |
frizzled class receptor 8 |
decreases expression |
EXP |
Glafenine results in decreased expression of FZD8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:57,312,924...57,320,551
Ensembl chr17:57,314,450...57,320,650
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of G6PC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases expression |
EXP |
Glafenine results in increased expression of G6PD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gab1 |
GRB2-associated binding protein 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of GAB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:27,131,262...27,239,236
Ensembl chr19:27,131,262...27,239,236
|
|
G |
Gabarapl1 |
GABA type A receptor associated protein like 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of GABARAPL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:162,980,309...162,989,452
Ensembl chr 4:162,980,249...162,989,450
|
|
G |
Gabarapl2 |
GABA type A receptor associated protein like 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of GABARAPL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:39,910,572...39,921,408
Ensembl chr19:39,910,534...39,924,628 Ensembl chr 8:39,910,534...39,924,628
|
|
G |
Gale |
UDP-galactose-4-epimerase |
increases expression |
EXP |
Glafenine results in increased expression of GALE mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:148,193,886...148,198,392
Ensembl chr 5:148,194,791...148,198,388
|
|
G |
Galk2 |
galactokinase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of GALK2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:113,110,057...113,243,014
Ensembl chr 3:113,110,030...113,233,306
|
|
G |
Galm |
galactose mutarotase |
decreases expression |
EXP |
Glafenine results in decreased expression of GALM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:14,837,540...14,889,484
Ensembl chr 6:14,837,548...14,889,310
|
|
G |
Galnt11 |
polypeptide N-acetylgalactosaminyltransferase 11 |
decreases expression |
EXP |
Glafenine results in decreased expression of GALNT11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:9,837,629...9,871,141
Ensembl chr 4:9,837,629...9,871,140
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
increases expression |
EXP |
Glafenine results in increased expression of GAPDH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gar1 |
GAR1 ribonucleoprotein |
increases expression |
EXP |
Glafenine results in increased expression of GAR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:218,375,231...218,382,509
Ensembl chr 2:218,375,353...218,382,524
|
|
G |
Gas5 |
growth arrest specific 5 |
increases expression |
EXP |
Glafenine results in increased expression of GAS5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:73,303,611...73,306,932
|
|
G |
Gas6 |
growth arrest specific 6 |
increases expression |
EXP |
Glafenine results in increased expression of GAS6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:76,045,430...76,075,904
Ensembl chr16:76,045,426...76,075,904
|
|
G |
Gbe1 |
1,4-alpha-glucan branching enzyme 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of GBE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:8,734,806...9,000,226
Ensembl chr11:8,734,820...9,000,210
|
|
G |
Gcdh |
glutaryl-CoA dehydrogenase |
decreases expression |
EXP |
Glafenine results in decreased expression of GCDH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:23,263,215...23,269,689
Ensembl chr19:23,263,264...23,269,681
|
|
G |
Gck |
glucokinase |
increases expression |
EXP |
Glafenine results in increased expression of GCK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
|
|
G |
Gckr |
glucokinase regulator |
decreases expression |
EXP |
Glafenine results in decreased expression of GCKR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:25,044,592...25,075,834
Ensembl chr 6:25,045,100...25,075,654
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
decreases expression |
EXP |
Glafenine results in decreased expression of GCLM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gcnt2 |
glucosaminyl (N-acetyl) transferase 2 |
increases expression |
EXP |
Glafenine results in increased expression of GCNT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:23,796,859...23,901,625
Ensembl chr17:23,796,859...23,901,611
|
|
G |
Gda |
guanine deaminase |
increases expression |
EXP |
Glafenine results in increased expression of GDA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
|
|
G |
Get4 |
guided entry of tail-anchored proteins factor 4 |
increases expression |
EXP |
Glafenine results in increased expression of GET4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:15,377,009...15,394,238
Ensembl chr12:15,377,009...15,394,053
|
|
G |
Gga2 |
golgi associated, gamma adaptin ear containing, ARF binding protein 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of GGA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:176,552,046...176,585,332
Ensembl chr 1:176,552,046...176,585,361
|
|
G |
Ggct |
gamma-glutamyl cyclotransferase |
increases expression |
EXP |
Glafenine results in increased expression of GGCT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:84,122,921...84,129,327
Ensembl chr 4:84,123,118...84,129,277
|
|
G |
Ggcx |
gamma-glutamyl carboxylase |
increases expression |
EXP |
Glafenine results in increased expression of GGCX mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:104,469,737...104,485,631
Ensembl chr 4:104,469,765...104,487,063
|
|
G |
Ghr |
growth hormone receptor |
decreases expression |
EXP |
Glafenine results in decreased expression of GHR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
increases expression |
EXP |
Glafenine results in increased expression of GJA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gk |
glycerol kinase |
decreases expression |
EXP |
Glafenine results in decreased expression of GK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
|
|
G |
Glb1 |
galactosidase, beta 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of GLB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
|
|
G |
Gls2 |
glutaminase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of GLS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:617,252...633,424
Ensembl chr 7:617,288...633,426
|
|
G |
Glt8d1 |
glycosyltransferase 8 domain containing 1 |
increases expression |
EXP |
Glafenine results in increased expression of GLT8D1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:6,192,269...6,207,227
Ensembl chr16:6,192,300...6,207,229
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of GLUD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
|
|
G |
Glyat |
glycine-N-acyltransferase |
decreases expression |
EXP |
Glafenine results in decreased expression of GLYAT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:209,704,213...209,724,949
Ensembl chr 1:209,704,268...209,724,942
|
|
G |
Glyr1 |
glyoxylate reductase 1 homolog |
decreases expression |
EXP |
Glafenine results in decreased expression of GLYR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:10,532,036...10,567,639
Ensembl chr10:10,532,154...10,567,637
|
|
G |
Gmcl1 |
germ cell-less 1, spermatogenesis associated |
decreases expression |
EXP |
Glafenine results in decreased expression of GMCL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:119,140,598...119,179,891
Ensembl chr 4:119,140,598...119,179,881
|
|
G |
Gmfg |
glia maturation factor, gamma |
increases expression |
EXP |
Glafenine results in increased expression of GMFG mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:83,728,797...83,739,189
Ensembl chr 1:83,728,776...83,739,183
|
|
G |
Gmppa |
GDP-mannose pyrophosphorylase A |
increases expression |
EXP |
Glafenine results in increased expression of GMPPA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:76,926,724...76,934,274
Ensembl chr 9:76,926,739...76,934,269
|
|
G |
Gmppb |
GDP-mannose pyrophosphorylase B |
increases expression |
EXP |
Glafenine results in increased expression of GMPPB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:108,737,429...108,740,437
Ensembl chr 8:108,693,060...108,767,286
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
increases expression |
EXP |
Glafenine results in increased expression of GNAI2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
|
|
G |
Gnat1 |
G protein subunit alpha transducin 1 |
increases expression |
EXP |
Glafenine results in increased expression of GNAT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:108,350,935...108,355,671
Ensembl chr 8:108,350,935...108,355,671
|
|
G |
Gnmt |
glycine N-methyltransferase |
decreases expression |
EXP |
Glafenine results in decreased expression of GNMT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
|
|
G |
Gns |
glucosamine (N-acetyl)-6-sulfatase |
decreases expression |
EXP |
Glafenine results in decreased expression of GNS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:56,889,148...56,923,173
Ensembl chr 7:56,889,232...56,923,151
|
|
G |
Gosr2 |
golgi SNAP receptor complex member 2 |
increases expression |
EXP |
Glafenine results in increased expression of GOSR2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:88,585,291...88,605,642
Ensembl chr10:88,586,299...88,605,625
|
|
G |
Gpat4 |
glycerol-3-phosphate acyltransferase 4 |
decreases expression |
EXP |
Glafenine results in decreased expression of GPAT4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:68,819,031...68,852,903
Ensembl chr16:68,819,079...68,852,901
|
|
G |
Gpbp1l1 |
GC-rich promoter binding protein 1-like 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of GPBP1L1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:130,009,768...130,050,636
Ensembl chr 5:130,023,137...130,050,459
|
|
G |
Gphn |
gephyrin |
decreases expression |
EXP |
Glafenine results in decreased expression of GPHN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:96,954,365...97,483,617
Ensembl chr 6:96,892,148...97,483,612
|
|
G |
Gpkow |
G patch domain and KOW motifs |
increases expression |
EXP |
Glafenine results in increased expression of GPKOW mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:14,791,601...14,806,384
Ensembl chr X:14,791,610...14,806,384
|
|
G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
decreases expression |
EXP |
Glafenine results in decreased expression of GPLD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:40,084,427...40,132,035
Ensembl chr17:40,084,617...40,126,939
|
|
G |
Gpr108 |
G protein-coupled receptor 108 |
increases expression |
EXP |
Glafenine results in increased expression of GPR108 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:2,120,740...2,131,771
Ensembl chr 9:2,120,744...2,132,572
|
|
G |
Gpr146 |
G protein-coupled receptor 146 |
increases expression |
EXP |
Glafenine results in increased expression of GPR146 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:15,251,936...15,267,217
Ensembl chr12:15,251,813...15,267,206
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
decreases expression |
EXP |
Glafenine results in decreased expression of GPT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpt2 |
glutamic--pyruvic transaminase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of GPT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:21,526,800...21,561,314
Ensembl chr19:21,517,621...21,560,610
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of GPX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Grsf1 |
G-rich RNA sequence binding factor 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of GRSF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:19,412,944...19,429,364
Ensembl chr14:19,412,156...19,429,362
|
|
G |
Gsap |
gamma-secretase activating protein |
increases expression |
EXP |
Glafenine results in increased expression of GSAP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:13,813,046...13,907,875
Ensembl chr 4:13,813,046...13,907,814
|
|
G |
Gsdmd |
gasdermin D |
decreases expression |
EXP |
Glafenine results in decreased expression of GSDMD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:107,542,489...107,547,051
Ensembl chr 7:107,542,083...107,547,055
|
|
G |
Gss |
glutathione synthetase |
increases expression |
EXP |
Glafenine results in increased expression of GSS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of GSTA3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Gstp3 |
glutathione S-transferase pi 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of GSTP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:201,355,682...201,358,216
Ensembl chr 1:201,355,682...201,358,330
|
|
G |
Gstt2 |
glutathione S-transferase theta 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of GSTT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:12,819,617...12,823,288
Ensembl chr20:12,819,170...12,823,288
|
|
G |
Gstz1 |
glutathione S-transferase zeta 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of GSTZ1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:106,794,594...106,805,284
Ensembl chr 6:106,794,074...106,805,284
|
|
G |
Gtf2f1 |
general transcription factor IIF subunit 1 |
increases expression |
EXP |
Glafenine results in increased expression of GTF2F1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:1,844,027...1,853,455
Ensembl chr 9:1,843,901...1,853,423
|
|
G |
Gtf2i |
general transcription factor II I |
decreases expression |
EXP |
Glafenine results in decreased expression of GTF2I mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:22,400,933...22,476,243
Ensembl chr12:22,401,431...22,476,243
|
|
G |
Gucd1 |
guanylyl cyclase domain containing 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of GUCD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:13,145,617...13,156,330
Ensembl chr20:13,146,076...13,156,328
|
|
G |
Gucy1a1 |
guanylate cyclase 1 soluble subunit alpha 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of GUCY1A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671
|
|
G |
Gusb |
glucuronidase, beta |
decreases expression |
EXP |
Glafenine results in decreased expression of GUSB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905
|
|
G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of HACL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:6,826,881...6,863,027
Ensembl chr16:6,824,906...6,863,027
|
|
G |
Hadh |
hydroxyacyl-CoA dehydrogenase |
decreases expression |
EXP |
Glafenine results in decreased expression of HADH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353
|
|
G |
Hal |
histidine ammonia lyase |
decreases expression |
EXP |
Glafenine results in decreased expression of HAL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:28,007,449...28,037,701
Ensembl chr 7:28,006,972...28,037,701
|
|
G |
Hdac2 |
histone deacetylase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of HDAC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
|
|
G |
Hdhd2 |
haloacid dehalogenase-like hydrolase domain containing 2 |
increases expression |
EXP |
Glafenine results in increased expression of HDHD2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:70,488,315...70,526,471
Ensembl chr18:70,474,926...70,526,470
|
|
G |
Hdlbp |
high density lipoprotein binding protein |
increases expression |
EXP |
Glafenine results in increased expression of HDLBP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:93,948,099...94,018,040
Ensembl chr 9:93,949,913...94,018,048
|
|
G |
Heca |
hdc homolog, cell cycle regulator |
decreases expression |
EXP |
Glafenine results in decreased expression of HECA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:12,525,445...12,575,358
Ensembl chr 1:12,525,135...12,576,427
|
|
G |
Hectd1 |
HECT domain E3 ubiquitin protein ligase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of HECTD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:69,181,429...69,268,045
Ensembl chr 6:69,181,436...69,268,053
|
|
G |
Hells |
helicase, lymphoid specific |
decreases expression |
EXP |
Glafenine results in decreased expression of HELLS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
|
|
G |
Hes6 |
hes family bHLH transcription factor 6 |
decreases expression |
EXP |
Glafenine results in decreased expression of HES6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:92,001,849...92,003,562
Ensembl chr 9:92,001,841...92,003,559
|
|
G |
Hexa |
hexosaminidase subunit alpha |
decreases expression |
EXP |
Glafenine results in decreased expression of HEXA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:59,936,526...59,961,654
Ensembl chr 8:59,936,660...59,962,013
|
|
G |
Hexb |
hexosaminidase subunit beta |
decreases expression |
EXP |
Glafenine results in decreased expression of HEXB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
|
|
G |
Hexim1 |
HEXIM P-TEFb complex subunit 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of HEXIM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:88,062,808...88,064,920
Ensembl chr10:88,062,803...88,066,189
|
|
G |
Hgd |
homogentisate 1, 2-dioxygenase |
decreases expression |
EXP |
Glafenine results in decreased expression of HGD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:63,086,750...63,138,325
Ensembl chr11:63,086,752...63,138,323
|
|
G |
Hibadh |
3-hydroxyisobutyrate dehydrogenase |
decreases expression |
EXP |
Glafenine results in decreased expression of HIBADH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:81,649,180...81,747,244
Ensembl chr 4:81,649,175...81,780,617
|
|
G |
Hibch |
3-hydroxyisobutyryl-CoA hydrolase |
decreases expression |
EXP |
Glafenine results in decreased expression of HIBCH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:48,590,097...48,669,896
Ensembl chr 9:48,590,099...48,669,824
|
|
G |
Higd1a |
HIG1 hypoxia inducible domain family, member 1A |
increases expression |
EXP |
Glafenine results in increased expression of HIGD1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:121,514,152...121,523,382
Ensembl chr 8:121,514,156...121,523,443
|
|
G |
Hint2 |
histidine triad nucleotide binding protein 2 |
increases expression |
EXP |
Glafenine results in increased expression of HINT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:57,904,613...57,906,868
Ensembl chr 5:57,904,614...57,907,097
|
|
G |
Hint3 |
histidine triad nucleotide binding protein 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of HINT3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:27,035,936...27,045,799
Ensembl chr 1:27,035,905...27,047,721
|
|
G |
Hipk2 |
homeodomain interacting protein kinase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of HIPK2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:67,439,327...67,619,223
Ensembl chr 4:67,440,501...67,619,223
|
|
G |
Hm13 |
histocompatibility minor 13 |
increases expression |
EXP |
Glafenine results in increased expression of HM13 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:141,145,792...141,183,557
Ensembl chr 3:141,145,782...141,184,703
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
increases expression |
EXP |
Glafenine results in increased expression of HMGCR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of HMGCS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
|
|
G |
Hmgn3 |
high mobility group nucleosomal binding domain 3 |
increases expression |
EXP |
Glafenine results in increased expression of HMGN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:84,022,493...84,059,329
Ensembl chr 8:84,022,495...84,062,976
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
increases expression |
EXP |
Glafenine results in increased expression of HNRNPA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
increases expression |
EXP |
Glafenine results in increased expression of HNRNPA2B1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
|
|
G |
Hoga1 |
4-hydroxy-2-oxoglutarate aldolase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of HOGA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:240,856,991...240,884,243
Ensembl chr 1:240,857,126...240,884,568
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
increases expression |
EXP |
Glafenine results in increased expression of HRAS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
decreases expression |
EXP |
Glafenine results in decreased expression of HSD17B10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:21,089,142...21,091,603
Ensembl chr X:21,089,122...21,109,488
|
|
G |
Hsd17b11 |
hydroxysteroid (17-beta) dehydrogenase 11 |
decreases expression |
EXP |
Glafenine results in decreased expression of HSD17B11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:5,693,304...5,743,157
Ensembl chr14:5,711,964...5,743,161
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of HSD17B2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
|
|
G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
decreases expression |
EXP |
Glafenine results in decreased expression of HSD17B4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952
|
|
G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
increases expression |
EXP |
Glafenine results in increased expression of HSD17B7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:82,170,079...82,190,018
Ensembl chr13:82,173,179...82,190,017
|
|
G |
Hsd3b7 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
decreases expression |
EXP |
Glafenine results in decreased expression of HSD3B7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:182,412,216...182,415,447
Ensembl chr 1:182,412,151...182,415,442
|
|
G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of HSDL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:74,443,933...74,479,104
Ensembl chr 5:74,443,872...74,479,839
|
|
G |
Hsf2 |
heat shock transcription factor 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of HSF2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:36,819,864...36,847,490
Ensembl chr20:36,819,864...36,850,174
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
increases expression |
EXP |
Glafenine results in increased expression of HSP90B1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspa13 |
heat shock protein family A (Hsp70) member 13 |
increases expression |
EXP |
Glafenine results in increased expression of HSPA13 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:14,375,669...14,389,853
Ensembl chr11:14,373,275...14,389,895
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
EXP |
Glafenine results in increased expression of HSPA5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hyal2 |
hyaluronidase 2 |
increases expression |
EXP |
Glafenine results in increased expression of HYAL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:108,241,895...108,246,853
Ensembl chr 8:108,243,133...108,246,850
|
|
G |
Hykk |
hydroxylysine kinase |
decreases expression |
EXP |
Glafenine results in decreased expression of HYKK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:55,315,919...55,339,720
Ensembl chr 8:55,315,969...55,337,339
|
|
G |
Hyls1 |
HYLS1, centriolar and ciliogenesis associated |
decreases expression |
EXP |
Glafenine results in decreased expression of HYLS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:33,912,692...33,921,760
Ensembl chr 8:33,912,692...33,921,760
|
|
G |
Hyou1 |
hypoxia up-regulated 1 |
increases expression |
EXP |
Glafenine results in increased expression of HYOU1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:44,706,073...44,718,189
Ensembl chr 8:44,706,263...44,718,186
|
|
G |
Hypk |
Huntingtin interacting protein K |
increases expression |
EXP |
Glafenine results in increased expression of HYPK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:108,434,997...108,436,370
Ensembl chr 3:108,432,539...108,436,370
|
|
G |
Iars2 |
isoleucyl-tRNA synthetase 2, mitochondrial |
decreases expression |
EXP |
Glafenine results in decreased expression of IARS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:96,831,484...96,865,518
Ensembl chr13:96,831,484...96,865,501
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
increases expression |
EXP |
Glafenine results in increased expression of ICAM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of ID2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Id4 |
inhibitor of DNA binding 4 |
decreases expression |
EXP |
Glafenine results in decreased expression of ID4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:16,389,387...16,391,956
Ensembl chr17:16,389,387...16,392,470
|
|
G |
Ier3 |
immediate early response 3 |
increases expression |
EXP |
Glafenine results in increased expression of IER3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ier5 |
immediate early response 5 |
increases expression |
EXP |
Glafenine results in increased expression of IER5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:67,270,134...67,272,226
Ensembl chr13:67,270,135...67,272,227
|
|
G |
Ifitm1 |
interferon induced transmembrane protein 1 |
increases expression |
EXP |
Glafenine results in increased expression of IFITM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
|
|
G |
Ifitm2 |
interferon induced transmembrane protein 2 |
increases expression |
EXP |
Glafenine results in increased expression of IFITM2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:196,051,539...196,052,719
Ensembl chr 1:196,051,537...196,052,741
|
|
G |
Ifitm3 |
interferon induced transmembrane protein 3 |
increases expression |
EXP |
Glafenine results in increased expression of IFITM3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
|
|
G |
Ifnar2 |
interferon alpha and beta receptor subunit 2 |
increases expression |
EXP |
Glafenine results in increased expression of IFNAR2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:30,613,576...30,645,958
Ensembl chr11:30,613,767...30,668,124
|
|
G |
Ift20 |
intraflagellar transport 20 |
increases expression |
EXP |
Glafenine results in increased expression of IFT20 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:63,432,597...63,438,125
Ensembl chr10:63,432,633...63,438,124
|
|
G |
Iftap |
intraflagellar transport associated protein |
decreases expression |
EXP |
Glafenine results in decreased expression of IFTAP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:87,812,068...87,906,517
Ensembl chr 3:87,817,408...87,906,547
|
|
G |
Igfals |
insulin-like growth factor binding protein, acid labile subunit |
decreases expression |
EXP |
Glafenine results in decreased expression of IGFALS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:13,897,468...13,903,920
Ensembl chr10:13,898,395...13,902,677
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of IGFBP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Il1b |
interleukin 1 beta |
increases expression |
EXP |
Glafenine results in increased expression of IL1B |
CTD |
PMID:24136188 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
increases expression |
EXP |
Glafenine results in increased expression of IL1RN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il6 |
interleukin 6 |
increases expression |
EXP |
Glafenine results in increased expression of IL6 |
CTD |
PMID:24136188 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Imp3 |
IMP U3 small nucleolar ribonucleoprotein 3 |
increases expression |
EXP |
Glafenine results in increased expression of IMP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:57,339,528...57,340,416
Ensembl chr 8:57,339,496...57,340,414
|
|
G |
Impa1 |
inositol monophosphatase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of IMPA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:91,462,781...91,484,057
Ensembl chr 2:91,462,799...91,484,313
|
|
G |
Ing1 |
inhibitor of growth family, member 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ING1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:77,937,276...77,945,320
Ensembl chr16:77,937,279...77,946,264
|
|
G |
Inmt |
indolethylamine N-methyltransferase |
decreases expression |
EXP |
Glafenine results in decreased expression of INMT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493
|
|
G |
Insig2 |
insulin induced gene 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of INSIG2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923
|
|
G |
Ipo4 |
importin 4 |
increases expression |
EXP |
Glafenine results in increased expression of IPO4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:29,117,365...29,127,382
Ensembl chr15:29,117,365...29,127,285
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
increases expression |
EXP |
Glafenine results in increased expression of IRAK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:151,768,621...151,778,521
Ensembl chr X:151,768,777...151,778,521
|
|
G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
increases expression |
EXP |
Glafenine results in increased expression of IRAK3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
|
|
G |
Irf6 |
interferon regulatory factor 6 |
decreases expression |
EXP |
Glafenine results in decreased expression of IRF6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:104,672,179...104,691,386
Ensembl chr13:104,672,179...104,691,386
|
|
G |
Isoc1 |
isochorismatase domain containing 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of ISOC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:52,158,790...52,179,206
Ensembl chr18:52,158,790...52,178,703
|
|
G |
Isyna1 |
inositol-3-phosphate synthase 1 |
increases expression |
EXP |
Glafenine results in increased expression of ISYNA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:18,839,143...18,841,979
Ensembl chr16:18,839,145...18,841,979
|
|
G |
Itgb1bp1 |
integrin subunit beta 1 binding protein 1 |
increases expression |
EXP |
Glafenine results in increased expression of ITGB1BP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:40,820,693...40,836,074
Ensembl chr 6:40,821,339...40,836,037
|
|
G |
Itpa |
inosine triphosphatase |
increases expression |
EXP |
Glafenine results in increased expression of ITPA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:117,885,464...117,897,247
Ensembl chr 3:117,885,099...117,897,249
|
|
G |
Iyd |
iodotyrosine deiodinase |
decreases expression |
EXP |
Glafenine results in decreased expression of IYD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
|
|
G |
Jam2 |
junctional adhesion molecule 2 |
increases expression |
EXP |
Glafenine results in increased expression of JAM2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:23,830,820...23,880,071
Ensembl chr11:23,831,106...23,880,063
|
|
G |
Jmjd1c |
jumonji domain containing 1C |
decreases expression |
EXP |
Glafenine results in decreased expression of JMJD1C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:21,332,147...21,494,220
Ensembl chr20:21,332,147...21,463,122
|
|
G |
Jmjd6 |
jumonji domain containing 6, arginine demethylase and lysine hydroxylase |
increases expression |
EXP |
Glafenine results in increased expression of JMJD6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:102,041,131...102,047,182
Ensembl chr10:102,041,120...102,047,182
|
|
G |
Josd2 |
Josephin domain containing 2 |
increases expression |
EXP |
Glafenine results in increased expression of JOSD2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:94,960,867...94,964,751
Ensembl chr 1:94,961,107...94,964,749
|
|
G |
Jpt2 |
Jupiter microtubule associated homolog 2 |
increases expression |
EXP |
Glafenine results in increased expression of JPT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:13,963,135...13,983,212
Ensembl chr10:13,963,137...13,983,170
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
Glafenine results in increased expression of JUNB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Kank1 |
KN motif and ankyrin repeat domains 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of KANK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:222,877,962...223,074,514
Ensembl chr 1:222,877,622...223,074,514
|
|
G |
Kat2b |
lysine acetyltransferase 2B |
decreases expression |
EXP |
Glafenine results in decreased expression of KAT2B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:6,562,525...6,667,064
Ensembl chr 9:6,562,288...6,667,064
|
|
G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
increases expression |
EXP |
Glafenine results in increased expression of KCNJ8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:175,508,908...175,515,829
Ensembl chr 4:175,508,912...175,515,603
|
|
G |
Kctd2 |
potassium channel tetramerization domain containing 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of KCTD2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:100,663,013...100,674,756
Ensembl chr10:100,662,884...100,674,336
|
|
G |
Kctd6 |
potassium channel tetramerization domain containing 6 |
decreases expression |
EXP |
Glafenine results in decreased expression of KCTD6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:16,695,297...16,712,460
Ensembl chr15:16,695,297...16,698,699
|
|
G |
Kctd9 |
potassium channel tetramerization domain containing 9 |
decreases expression |
EXP |
Glafenine results in decreased expression of KCTD9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:41,942,165...41,969,862
Ensembl chr15:41,942,381...41,969,862
|
|
G |
Kdelr2 |
KDEL endoplasmic reticulum protein retention receptor 2 |
increases expression |
EXP |
Glafenine results in increased expression of KDELR2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:11,138,820...11,157,117
Ensembl chr12:11,138,820...11,157,153
|
|
G |
Kdm1b |
lysine demethylase 1B |
decreases expression |
EXP |
Glafenine results in decreased expression of KDM1B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:17,602,961...17,643,865
Ensembl chr17:17,602,961...17,643,800
|
|
G |
Kdr |
kinase insert domain receptor |
decreases expression |
EXP |
Glafenine results in decreased expression of KDR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Khk |
ketohexokinase |
decreases expression |
EXP |
Glafenine results in decreased expression of KHK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:25,445,298...25,455,834
Ensembl chr 6:25,445,300...25,455,717
|
|
G |
Klc4 |
kinesin light chain 4 |
decreases expression |
EXP |
Glafenine results in decreased expression of KLC4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:14,337,164...14,351,075
Ensembl chr 9:14,337,534...14,351,066
|
|
G |
Klf3 |
KLF transcription factor 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of KLF3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:43,474,767...43,505,801
Ensembl chr14:43,474,767...43,497,209
|
|
G |
Klhl25 |
kelch-like family member 25 |
decreases expression |
EXP |
Glafenine results in decreased expression of KLHL25 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:129,724,894...129,750,142
Ensembl chr 1:129,722,026...129,750,227
|
|
G |
Klhl7 |
kelch-like family member 7 |
decreases expression |
EXP |
Glafenine results in decreased expression of KLHL7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:11,006,366...11,055,399
Ensembl chr 4:11,006,375...11,055,541
|
|
G |
Kng1 |
kininogen 1 |
increases expression |
EXP |
Glafenine results in increased expression of KNG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
|
|
G |
Kpna2 |
karyopherin subunit alpha 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of KPNA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
|
|
G |
Krt18 |
keratin 18 |
increases expression |
EXP |
Glafenine results in increased expression of KRT18 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
|
|
G |
Krtcap2 |
keratinocyte associated protein 2 |
increases expression |
EXP |
Glafenine results in increased expression of KRTCAP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:174,654,409...174,658,405
Ensembl chr 2:174,654,219...174,658,405
|
|
G |
Kyat1 |
kynurenine aminotransferase 1 |
increases expression |
EXP |
Glafenine results in increased expression of KYAT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:13,459,598...13,493,308
Ensembl chr 3:13,459,591...13,493,355
|
|
G |
Kyat3 |
kynurenine aminotransferase 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of KYAT3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:231,701,881...231,747,462
Ensembl chr 2:231,701,963...231,747,227
|
|
G |
Kynu |
kynureninase |
decreases expression |
EXP |
Glafenine results in decreased expression of KYNU mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488
|
|
G |
L2hgdh |
L-2-hydroxyglutarate dehydrogenase |
decreases expression |
EXP |
Glafenine results in decreased expression of L2HGDH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:88,164,429...88,205,585
Ensembl chr 6:88,164,440...88,205,578
|
|
G |
Lactb2 |
lactamase, beta 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of LACTB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:5,569,080...5,591,843
Ensembl chr 5:5,569,067...5,596,429
|
|
G |
Lage3 |
L antigen family, member 3 |
increases expression |
EXP |
Glafenine results in increased expression of LAGE3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:152,138,209...152,139,632
Ensembl chr X:152,138,218...152,139,632
|
|
G |
Lamtor3 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3 |
increases expression |
EXP |
Glafenine results in increased expression of LAMTOR3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:226,411,389...226,423,612
Ensembl chr 2:226,411,400...226,423,607
|
|
G |
Larp1b |
La ribonucleoprotein 1B |
decreases expression |
EXP |
Glafenine results in decreased expression of LARP1B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:123,936,057...123,969,254
Ensembl chr 2:123,935,983...123,968,896
|
|
G |
Lbp |
lipopolysaccharide binding protein |
increases expression |
EXP |
Glafenine results in increased expression of LBP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
|
|
G |
Lcn2 |
lipocalin 2 |
increases expression |
EXP |
Glafenine results in increased expression of LCN2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Ldaf1 |
lipid droplet assembly factor 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of LDAF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:174,484,438...174,503,037
Ensembl chr 1:174,484,447...174,503,036
|
|
G |
Ldhd |
lactate dehydrogenase D |
decreases expression |
EXP |
Glafenine results in decreased expression of LDHD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:39,583,529...39,588,397
Ensembl chr19:39,573,621...39,595,575
|
|
G |
Lenep |
lens epithelial protein |
increases expression |
EXP |
Glafenine results in increased expression of LENEP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:174,819,439...174,820,127
Ensembl chr 2:174,819,459...174,820,127
|
|
G |
Lgals3 |
galectin 3 |
increases expression |
EXP |
Glafenine results in increased expression of LGALS3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
|
|
G |
Lgals8 |
galectin 8 |
decreases expression |
EXP |
Glafenine results in decreased expression of LGALS8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:58,024,652...58,052,764
Ensembl chr17:58,028,105...58,052,764
|
|
G |
Lhpp |
phospholysine phosphohistidine inorganic pyrophosphate phosphatase |
decreases expression |
EXP |
Glafenine results in decreased expression of LHPP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:187,403,390...187,494,577
Ensembl chr 1:187,403,433...187,494,578
|
|
G |
Lias |
lipoic acid synthetase |
decreases expression |
EXP |
Glafenine results in decreased expression of LIAS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:42,876,699...42,893,824
Ensembl chr14:42,876,699...42,893,783
|
|
G |
Lin7a |
lin-7 homolog A, crumbs cell polarity complex component |
increases expression |
EXP |
Glafenine results in increased expression of LIN7A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:42,586,704...42,742,609
Ensembl chr 7:42,586,719...42,730,550
|
|
G |
Lipa |
lipase A, lysosomal acid type |
decreases expression |
EXP |
Glafenine results in decreased expression of LIPA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:232,024,351...232,057,735
Ensembl chr 1:232,024,356...232,057,633
|
|
G |
Lipc |
lipase C, hepatic type |
decreases expression |
EXP |
Glafenine results in decreased expression of LIPC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
|
|
G |
Lman1 |
lectin, mannose-binding, 1 |
increases expression |
EXP |
Glafenine results in increased expression of LMAN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:59,508,996...59,530,873
Ensembl chr18:59,508,996...59,530,851
|
|
G |
Lnx2 |
ligand of numb-protein X 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of LNX2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:8,005,202...8,070,494
Ensembl chr12:8,005,227...8,070,494
|
|
G |
Lonp2 |
lon peptidase 2, peroxisomal |
decreases expression |
EXP |
Glafenine results in decreased expression of LONP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:20,407,475...20,498,985
Ensembl chr19:20,407,477...20,499,014
|
|
G |
Lpar6 |
lysophosphatidic acid receptor 6 |
decreases expression |
EXP |
Glafenine results in decreased expression of LPAR6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:48,416,548...48,418,357
Ensembl chr15:48,416,544...48,422,331
|
|
G |
Lpgat1 |
lysophosphatidylglycerol acyltransferase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of LPGAT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:103,294,622...103,365,372
Ensembl chr13:103,294,528...103,362,333
|
|
G |
Lrat |
lecithin retinol acyltransferase |
decreases expression |
EXP |
Glafenine results in decreased expression of LRAT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619
|
|
G |
Lrg1 |
leucine-rich alpha-2-glycoprotein 1 |
increases expression |
EXP |
Glafenine results in increased expression of LRG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:947,516...949,773
Ensembl chr 9:947,516...949,813
|
|
G |
Lrrc40 |
leucine rich repeat containing 40 |
decreases expression |
EXP |
Glafenine results in decreased expression of LRRC40 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:247,101,518...247,131,061
Ensembl chr 2:247,101,500...247,131,059
|
|
G |
Lrrc59 |
leucine rich repeat containing 59 |
increases expression |
EXP |
Glafenine results in increased expression of LRRC59 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:79,572,295...79,586,953
Ensembl chr10:79,572,317...79,602,533
|
|
G |
Lrrc8d |
leucine rich repeat containing 8 VRAC subunit D |
decreases expression |
EXP |
Glafenine results in decreased expression of LRRC8D mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:4,029,971...4,134,922
Ensembl chr14:4,029,473...4,135,877
|
|
G |
Lsm4 |
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated |
increases expression |
EXP |
Glafenine results in increased expression of LSM4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:18,755,481...18,761,106
Ensembl chr16:18,755,484...18,760,926
|
|
G |
Lsm8 |
LSM8 homolog, U6 small nuclear RNA associated |
increases expression |
EXP |
Glafenine results in increased expression of LSM8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:47,306,259...47,312,125
Ensembl chr 4:47,306,295...47,314,293
|
|
G |
Ltb |
lymphotoxin beta |
increases expression |
EXP |
Glafenine results in increased expression of LTB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381
|
|
G |
Ltn1 |
listerin E3 ubiquitin protein ligase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of LTN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:26,603,903...26,660,871
Ensembl chr11:26,603,903...26,660,886
|
|
G |
Lurap1l |
leucine rich adaptor protein 1-like |
increases expression |
EXP |
Glafenine results in increased expression of LURAP1L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:95,362,005...95,409,439
Ensembl chr 5:95,362,005...95,409,438
|
|
G |
Lypla1 |
lysophospholipase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of LYPLA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:14,679,605...14,708,774
Ensembl chr 5:14,679,606...14,708,746
|
|
G |
Lyplal1 |
lysophospholipase-like 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of LYPLAL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:97,626,568...97,657,901
Ensembl chr13:97,626,451...97,657,867
|
|
G |
Lysmd2 |
LysM domain containing 2 |
increases expression |
EXP |
Glafenine results in increased expression of LYSMD2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:76,378,984...76,394,396
Ensembl chr 8:76,379,219...76,394,654
|
|
G |
Lyz2 |
lysozyme 2 |
increases expression |
EXP |
Glafenine results in increased expression of LYZ2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:52,906,810...52,912,154
Ensembl chr 7:52,906,811...52,912,106
|
|
G |
Macrod1 |
mono-ADP ribosylhydrolase 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of MACROD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:204,246,238...204,387,027
Ensembl chr 1:204,246,166...204,389,716
|
|
G |
Maea |
macrophage erythroblast attacher, E3 ubiquitin ligase |
decreases expression |
EXP |
Glafenine results in decreased expression of MAEA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:77,357,261...77,390,683
Ensembl chr14:77,357,264...77,390,671
|
|
G |
Mafb |
MAF bZIP transcription factor B |
decreases expression |
EXP |
Glafenine results in decreased expression of MAFB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
|
|
G |
Magoh |
mago homolog, exon junction complex subunit |
increases expression |
EXP |
Glafenine results in increased expression of MAGOH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:122,639,268...122,646,650
Ensembl chr 5:122,639,308...122,646,617
|
|
G |
Man1b1 |
mannosidase, alpha, class 1B, member 1 |
increases expression |
EXP |
Glafenine results in increased expression of MAN1B1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:8,143,877...8,165,007
Ensembl chr 3:8,143,381...8,165,006
|
|
G |
Man2b1 |
mannosidase, alpha, class 2B, member 1 |
decreases expression |
EXP |
Glafenine results in decreased expression of MAN2B1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:23,055,092...23,074,398
Ensembl chr19:23,055,097...23,074,389
|
|
G |
Manf |
mesencephalic astrocyte-derived neurotrophic factor |
increases expression |
EXP |
Glafenine results in increased expression of MANF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:107,500,856...107,551,595
Ensembl chr 8:107,548,352...107,551,438
|
|
G |
Maob |
monoamine oxidase B |
decreases expression |
EXP |
Glafenine results in decreased expression of MAOB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
increases expression |
EXP |
Glafenine results in increased expression of MAP1LC3B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Map2k3 |
mitogen activated protein kinase kinase 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of MAP2K3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
|
|
G |
Map4k3 |
mitogen-activated protein kinase kinase kinase kinase 3 |
decreases expression |
EXP |
Glafenine results in decreased expression of MAP4K3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:14,276,623...14,446,321
Ensembl chr 6:14,277,121...14,446,334
|
|
G |
Mapk8ip3 |
mitogen-activated protein kinase 8 interacting protein 3 |
increases expression |
EXP |
Glafenine results in increased expression of MAPK8IP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:13,918,417...13,958,335
Ensembl chr10:13,918,400...13,958,273
|
|
G |
Mapkapk5 |
MAPK activated protein kinase 5 |
increases expression |
EXP |
Glafenine results in increased expression of MAPKAPK5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:34,993,520...35,013,059
Ensembl chr12:34,994,092...35,013,052
|
|
G |
Mapre1 |
microtubule-associated protein, RP/EB family, member 1 |
increases expression |
EXP |
Glafenine results in increased expression of MAPRE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:142,218,846...142,246,990
Ensembl chr 3:142,212,955...142,246,983
|
|
G |
Marchf2 |
membrane associated ring-CH-type finger 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of MARCHF2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:14,480,605...14,507,821
Ensembl chr 7:14,481,761...14,507,794
|
|
G |
Marchf6 |
membrane associated ring-CH-type finger 6 |
decreases expression |
EXP |
Glafenine results in decreased expression of MARCHF6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:82,455,686...82,532,917
Ensembl chr 2:82,455,689...82,532,910
|
|
G |
Mbd3 |
methyl-CpG binding domain protein 3 |
increases expression |
EXP |
Glafenine results in increased expression of MBD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:9,312,961...9,320,166
Ensembl chr 7:9,313,098...9,320,165
|
|
G |
Mbl2 |
mannose binding lectin 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of MBL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:228,016,439...228,024,736
|
|
G |
Mbnl2 |
muscleblind-like splicing regulator 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of MBNL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:97,385,278...97,542,924
Ensembl chr15:97,385,244...97,542,937
|
|
G |
Mccc2 |
methylcrotonyl-CoA carboxylase subunit 2 |
decreases expression |
EXP |
Glafenine results in decreased expression of MCCC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:31,304,927...31,375,978
Ensembl chr 2:31,304,932...31,375,972
|
|
G |
Mcts2 |
MCTS family member 2 |
increases expression |
EXP |
Glafenine results in increased expression of MCTS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:141,163,330...141,164,108
|
|
| |